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Uterine contractions are tightly regulated throughout pregnancy, remaining relatively 
quiescent for the majority of pregnancy to promote fetal development, while becoming highly 
activated at term to effectively expel the fetus.  Contractions are coordinated through electrical 
and mechanical coupling of myometrial smooth muscle cells (MSMCs).  Ion channel activity, 
which alters the electrical activity of MSMCs, can directly affect the contraction profile.  Thus 
there is great interest in the field of reproduction to understand which ion channels regulate 
uterine excitability, and particularly how they may enable the transition from uterine quiescence 
to uterine activation for labor.  The focus thus far has been primarily on Ca2+ and K+ channels, 
however, in these studies, we identified the expression of a novel Na+ leak channel (NALCN) in 
the human and mouse myometrium that has a direct effect on uterine excitability.  In the human 
myometrium, NALCN contributes to a Gd3+-sensitive, Na+-dependent leak current.  To study its 
role in vivo, we created a smooth muscle specific NALCN knockout mouse.  These mice had 
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reduced myometrial excitability exemplified by shortening of action potential bursts, and an 
increased rate of prolonged and dysfunctional labor.  Further implicating a role for NALCN in 
parturition, we found that NALCN protein levels were negatively regulated by progesterone, an 
important hormone in sustaining uterine quiescence, and that progesterone upregulates a novel, 
glycosylated isoform of NALCN.  Our findings are significant in that we found NALCN 
contributes to the myometrial action potential, and that Na+ channel contributions are important 
for successful labor outcomes.   
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Chapter 1: Introduction 
1.1 Parturition 
Pregnancy is one of the greatest physiological challenges that a woman’s body endures.  
From conception to parturition, the female body undergoes a vast array of changes in order to 
adapt to and support the developing fetus. These changes range from metabolic reallocation, to 
suppression of the immune system toward the allogeneic fetus, to major cardiovascular 
adjustments, such as increased blood volume and cardiac output.  The extreme physical demands 
of pregnancy culminate with the final step, parturition.  Although parturition represents only a 
short period of time compared to the full duration of pregnancy and the future life of the 
offspring, it is crucial in determining the overall success of pregnancy and setting the stage for a 
healthy life.  Despite knowing its clear importance in human survival, we still lack a complete 
understanding of the physiological and molecular mechanisms involved in successful parturition, 
including those which coordinate uterine contractions. 
During normal pregnancy, the uterus undergoes rapid growth and functional 
modifications.   The human uterus grows to be ~30 times its non-pregnant weight (1) and it does 
so by both increasing cell number (hyperplasia) and cell size (hypertrophy) (2).  The uterus also 
changes in morphology, shifting from a small, pear-shaped organ, to a large balloon-like 
structure characterized by a thick-walled, contractile upper segment and thin-walled passive 
lower segment.  Blood vessels stemming from the placenta penetrate the uterine wall, and the 
uterine artery increases its blood flow to provide nutrients to the fast growing fetus and uterine 
muscle. During pregnancy, the uterus also undergoes denervation, showing loss of cholinergic 
and adrenergic nerve terminals in uterine tissue (3-6).  While all of these physiological 
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accommodations are occurring, this ordinarily contractile organ must remain quiescent 
throughout the majority of pregnancy but then rapidly transition to a state of activation at term.  
All of these transformations are mediated at the cell level by dynamic changes in gene 
expression, post-translational regulation, and cell-to-cell communication and migration.  Since 
pregnancy and parturition rely heavily on the strict spatial and temporal regulation of a large and 
complex network of genes and interacting tissues, even small disruptions or environmental 
insults can result in adverse outcomes.   
A number of adverse pregnancy outcomes center around dysfunctional uterine 
contractility.  At one end of the spectrum, the uterus is overactive, contracting so forcefully or 
rapidly (tachysystole) during parturition that if left untreated endangers the fetus by causing 
ischemia and abnormal fetal heart rate.  Although the uterine smooth muscle layer (myometrium) 
shows contractions at any point in pregnancy, these contractions tend to be weak and 
asynchronous and do not result in labor.  Thus, another form of uterine ‘hyperactivity’ is when 
the uterus pathologically demonstrates spontaneous premature labor-quality contractions, and 
causes preterm birth. Preterm birth (birth before 37 weeks gestation) occurs in 10% of births in 
the Unites States (7), and is the leading cause of neonatal death and morbidity in the world 
(World Health Organization).  About 30% of PTB is caused by preterm premature rupture of 
membranes (rupture of fetal membranes before 37 weeks gestation), ~20% are medically 
indicated and result from elective caesarean sections, and the remaining ~50% are considered 
idiopathic (8).  Unfortunately, current contraction inhibiting drugs (tocolytics) used to prevent or 
halt preterm birth, such as the calcium channel blocker, nifedipine, or the beta-adrenergic 
receptor agonist, terbutaline, are ineffective at delaying labor for more than 48 hrs – 7 days (9).   
Treatment with vaginal progesterone or cervical cerclage have been effective in reducing preterm 
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birth rates in women with a prior preterm birth or short cervix (10-13), but this has only reduced 
the overall preterm birth rate in the US by 1.4% (14).  Thus, preterm birth remains the highest 
motivating factor for better understanding uterine contractility and parturition.  
At the other end of the spectrum is dystocia, when the uterus does not contract 
sufficiently during parturition.  Dystocia can prolong labor and increase morbidity for both 
mother and child.   Hypocontractility also contributes to post-term pregnancies.  When a 
woman’s uterus fails to initiate contractions at term, the pregnancy is at a greater risk of resulting 
in stillbirth, perinatal death, shoulder dystocia, fetal macrosomia, meconium aspiration 
syndrome, and severe perineal lacerations (15).  Women are often given the contraction agonist 
oxytocin to induce labor or augment contractions in the case of dystocia, but this is not effective 
for many women and can have adverse outcomes (16, 17).  Beyond oxytocin treatment, 
caesarean section is often the next line of treatment.  Currently, caesarean sections account for 
32% of births in the United States, a rate that is more than triple what is considered necessary for 
maintaining the lowest infant and maternal mortality rate (18).  Many health agencies (ACOG, 
SMFM, CDC, WHO) are advocating to reduce the caesarean section rate, in part by encouraging 
further research into understanding normal labor progression (19). Thus, it is imperative for the 
health of women and babies that we better understand the dynamic regulation of uterine 
contractility so that we can improve pregnancy and parturition outcomes. 
1.2 Uterine Contractions and Physiology 
1.2.1 Uterine Anatomy 
Uterine contractions are important in many stages of the female reproductive cycle, 
including menstruation, sperm transport, embryo implantation, and parturition.  The main tissue 
of the uterus that drives these contractions is called the myometrium, and it performs its 
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contractile function through the work of individual myometrial smooth muscle cells (MSMCs).  
The bulk of MSMCs in the uterus are organized into a thick outer layer, that runs longitudinally, 
and this is the layer responsible for labor contractions (20).  There is also evidence for a thin sub-
endometrial layer, where MSMCs are organized in a transverse, circular orientation (21, 22).  It 
is hypothesized that this layer may contribute more to the peristaltic like activity observed during 
the menstrual cycle (21, 23).  In the rodent, the layers are subdivided into a luminal circular 
layer, and an outer longitudinal layer.  The longitudinal muscle layer more closely mimics the 
longitudinally oriented fibers of the human myometrium, and because of ease of manipulation, is 
more widely used in tissue physiology experiments.  
1.2.2 Mechanisms of MSMC Contractions 
Uterine contractions are mediated by the molecular motors actin and myosin within 
MSMCs. The shortening the actomyosin filaments, through a process termed cross-bridge 
cycling (24), results in shortening of the smooth muscle cell and contraction of the tissue.  Cross-
bridge cycling is heavily dependent on the intracellular Ca2+ concentration ([Ca2+]i) (25).  Ca2+ 
maintains a large chemical gradient in MSMCs where the extracellular Ca2+ concentration is near 
1.5 mM and the [Ca2+]i is closer to 130 nM (21, 26).  When [Ca2+]i increases, Ca2+ ions are bound 
up by the cytosolic protein calmodulin, which then activates myosin light chain kinase (MLCK) 
and initates the cross-bridge cycling cascade (27).  Thus, increases in [Ca2+]i directly coincide 
with increased contractility.  Therefore, mechanisms regulating MSMC [Ca2+]i are key to the 
regulation of uterine contractions as a whole.  Increases in [Ca2+]i are mediated by two primary 
pathways, influx from the extracellular space through voltage gated Ca2+ channels, and efflux 
from the intracellular stores through ligand gated Ca2+ channels (Figure 1.1). 
Excitation-Contraction (EC) Coupling in MSMCs 





Figure 1.1 Abbreviated components of the excitation-contraction coupling pathway.  
Depolarization of the membrane potential through a Na+ leak current (Na+ Leak Channel, Non-Selective 
(NALCN)) activates L-type Ca2+ channels, and drives Ca2+ influx. Intracellular Ca2+ binds calmodulin to 
activate mysoin light chain kinase (MLCK), which phosphorylates myosin and initiates actomyosin cross-
bridge cycling to initiate contraction.  Intracellular Ca2+ can also increase through the activation of G-
protein coupled receptors (GPCRs) like the oxytocin receptor (OXTR).  Upon ligand binding, OXTR 
initiates a signaling cascade, which results in the production of IP3 and activates the IP3 receptor (IP3R).  
IP3R releases Ca2+ from the sarcoplasmic reticulum.  Upon cell membrane depolarization and increased 
intracellular Ca2+, voltage and Ca2+ activated K+ channels, such as small conductance calcium activated 
channel 3 (SK3) and large conductance, calcium and voltage gated potassium channel (BKCa) open to 
repolarize the membrane potential.  Simultaneously, plasma membrane calcium ATPase (PMCA), and 
sarcoendoplasmic reticulum calcium ATPase (SERCA) work to pump Ca2+ out of the cell and into the 
sarcoplasmic reticulum respectively, resulting in MSMC relaxation.
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increased and decreased through modulation of the MSMC membrane potential.  One of the 
main drivers of this process, termed excitation-contraction coupling (28), is the L-type Ca2+ 
channel (26, 29).  Upon membrane depolarization, these channels open and conduct a large 
influx of Ca2+ into the cell.  They are considered high-voltage activating channels, and in the 
myometrium their activation threshold is near -40 mV (30).  These channels have a single 
channel conductance near 20 pS, and are slow to both activate and inactivate (31, 32).  Their 
ability to remain open for an extended period of time (tens to hundreds of milliseconds (33), not 
only generates the increase in [Ca2+]i necessary for contraction, but also gives rise to the 
characteristic slow bursting action potentials of the myometrium (Figure 1.2).  Together Ca2+-
efflux from intracellular stores and Ca2+-influx from the extracellular fluid work in a feed 
forward fashion to create strong and sustained contractions. 
 In order to relax, MSMCs reduce the [Ca2+]i to resting conditions.  Upon membrane 
depolarization, voltage-gated and Ca2+-activated K+ channels become activated (34).  Because 
the [K+] is much higher inside of the cell (140 mM) than it is outside of the cell (5 mM), the 
opening of K+ channels will result in K+ flowing out of the cell to repolarize the cell membrane 
to more negative potentials (-55 mV).  Repolarization of the membrane will then inactivate 
voltage-gated Ca2+ channels, thereby blocking the influx of Ca2+.  Simultaneously, the plasma 
membrane Ca2+-ATPase (PMCA) and the sarcoendoplasmic reticulum Ca2+-ATPase  (SERCA) 
work to pump Ca2+ back out of the cell and into the sarcoplasmic reticulum (SR), respectively 
(35).  The opposing actions of Ca2+ channels, Ca2+ pumps, K+ channels, and other ion channels 
(both identified and remaining to be discovered) result in a bursting action potential (Figure 1.2) 
(36).  Processes that alter Ca2+-handling and membrane potential can alter the shape and duration 





Figure 1.2 Schematic of myometrial action potentials (bursts).   
Slow depolarization of the resting membrane potential produces a pacemaker potential that drives the cell 
to its threshold potential.  At the threshold potential (~-40 mV), voltage-gated Ca2+channels open leading 
to MSMC depolarization.  A burst of depolarizing spikes develops as Ca2+ channels continue to activate 
and inactivate, and voltage-gated and Ca2+ activated K+ channels activate to drive K+-efflux and 
repolarization.  The balance of depolarizing and repolarizing currents expressed by the cell can change the 
burst duration (from first spike to last spike) and burst interval (from last spike of previous burst to first 
spike of following burst).
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Ligand-Mediated Excitation-Contraction Coupling 
Ligands which increase uterine contractility are called uterotonins, and they primarily 
function by directly, or indirectly increasing [Ca2+]i.  One of the most well studied uterotonins 
that functions through the Ca2+-efflux pathway is oxytocin.  Oxytocin is a nonapeptide hormone 
that initiates uterine contractility through its binding to the oxytocin receptor, a member of the G-
protein coupled receptor family. Upon oxytocin binding, the OXTR undergoes a conformational 
change that activates its associated Gαq/11 protein, leading to multiple downstream signaling 
pathways resulting in myometrial contraction (38).  The primary pathway involves Gαq/11 
activation of phospholipase C-β and production of diacylglycerol and inositol triphosphate (IP3) 
from phosphotidyl inositol.  IP3 activates the IP3 receptor on the sarcoplasmic reticulum, which 
opens and releases Ca2+ from the SR into the cytosol.  The increase in [Ca2+]i  induces Ca2+-
calmodulin binding and initiates the cross-bridge cycling cascade (reviewed in(39)).   
Cross-Bridge Cycling 
Upon the increased [Ca2+]i, calmodulin activates MLCK to phosphorylate myosin and 
initiate cross-bridge cycling with actin.  Actin filaments, anchored to the dense bodies of the 
cytoskeleton, are juxtaposed to myosin thick filaments that are composed of two regulatory light 
chains, and two heavy chains.  The heavy chains each contain a head region with an actin 
binding domain and an ATPase domain that produces the energy required for the force of 
contraction.  To initiate contractions, the myosin light chains are phosphorylated by MLCK, 
inducing the ATPase activity of the heavy chains and increasing the angle of the myosin heads in 
relation to the actin filaments.  This results in the myosin thick filaments pulling the actin 
filaments towards the center of the cell, thereby decreasing the length of the cell, and shortening 
the muscle.  To finish the cycle, myosin thick filaments release their ADP, bind an ATP and are 
released from the actin filament, ready to start again (reviewed in (21)).  
9 
 
1.3 Uterine Activation 
 Throughout pregnancy the uterus remains quiescent, producing low amplitude, 
asynchronous contractions.  At term, it undergoes a period of activation, in which it becomes 1) 
more sensitive to stimulation by agonists like oxytocin, 2) more sensitized to Ca2+, 3) more 
electrically connected such that it can produce coordinated contractions, and 4) able to produce 
stronger contractions per unit area (40).  In preparation for labor, human MSMCs increase the 
expression of the oxytocin receptor while simultaneously, the decidua increases local oxytocin 
production (39).  In addition to increasing [Ca2+]i, oxytocin signaling also promotes greater force 
production in response to [Ca2+]i than depolarization alone.  This effect, known as calcium 
sensitization, occurs as the result of myosin light chain phosphatase (MLCP) inhibition.  MLCP, 
which normally encourages muscle relaxation, is inhibited by the RhoA-associated kinase 
(ROCK) upon oxytocin receptor stimulation (41).  This in turn gives oxytocin a two-pronged 
approach for enhancing uterine contractility at term.  The effects of local [Ca2+]i increases in the 
uterus are further amplified at term by the increased expression of the gap junction protein, 
connexin 43 (Cx43) (42, 43).  Greater connectivity between MSMCs through gap junctions 
promotes whole-organ level, wave-like contractions that are necessary for parturition.  Finally, 
contractions that occur during labor are more effective at expelling the fetus because they are 
stronger.  Not only is there increased Ca2+ signaling (44), but it has been shown that force per 
unit of phosphorylated myosin light chain increases through an unknown mechanism (40). 
1.4 Hormonal Coordination of Uterine Physiology 
Uterine physiology is regulated throughout pregnancy in large part by the actions of the 
steroid hormones progesterone and estrogen.  Progesterone, named for its pro-gestational effects, 
increases in serum concentration throughout pregnancy in both rodents and humans and serves to 
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block uterine contractions (45).  The ‘progesterone-block’ is so essential that treatment with the 
progesterone receptor partial-antagonist, RU486, initiates labor at any point in pregnancy, and 
does so in both rodents and humans (46).  Progesterone maintains uterine quiescence by 
inhibiting the expression of many pro-contractile, estrogen-mediated genes, such as the oxytocin 
receptor, the prostaglandin F2α receptor, and connexin 43 in part by activating the repressive 
transcription factors ZEB1 and ZEB2 (47, 48).  Additionally, progesterone maintains the PKA-
mediated block of phospholipase C-β, thereby preventing the Ca2+-efflux cascade initiated by 
oxytocin and prostaglandin F2α (48, 49).  Importantly, the mechanism of progesterone withdrawal 
at term differs between humans and rodents.  Rodents experience a loss of circulating 
progesterone at term due to the break down of their primary progesterone producing organ, the 
corpus luteum, triggered by decidual prostaglandin synthesis.  Conversely, in women high 
progesterone levels, produced by the placenta, are sustained until term (50, 51).  This has lead to 
the hypothesis that in lieu of a drop in circulating progesterone, pregnant women experience a 
functional progesterone withdrawal to induce labor (52).   
The human nuclear progesterone receptor has two main isoforms, PR-A and PR-B.  PR-B 
encompasses the full length protein, whereas PR-A is a truncated form of the receptor resulting 
from the use of a downstream alternative promoter within the first exon (53).  PR-A and PR-B 
share most of the same structural motifs including a DNA-binding motif, ligand binding domain, 
and hinge region (54).  The two receptors only differ by the N-terminal regulatory domain, with 
PR-A being 164 amino acids shorter than PR-B.  This structural alteration promotes differing 
activities between the two receptors.  PR-A, thought to be less transcriptionally active, was 
shown to oppose the actions of PR-B especially when the PR-A:PR-B ratio is high (55).   Sam 
Mesiano’s laboratory has shown that PR-A expression increases in term laboring samples 
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compared to non-laboring samples, thereby increasing the PR-A:PR-B ratio and enhancing the 
block of PR-B target genes (56).  Conversely, PR-A has been shown to transactivate the 
expression of its own unique subset of target genes, and like PR-B, often does so in coordination 
with other transcription factors in the absence of a progesterone response element (55, 57).  
Recently, Nadeem et al. demonstrated that PR-A can translocate to the nucleus and induce the 
expression of connexin 43, in an unliganded state (58).  They showed that term MSMCs express 
high levels of 20α hydroxysteroid dehydrogenase, which breaks down progesterone, creating a 
low progesterone concentration within the local environment.  Because PR-B remains inactive in 
the unliganded state, PR-A becomes the dominant form of the receptor at term.  Together, these 
studies suggest that the effects of progesterone will differ depending on its levels, the PR-A:PR-
B ratio, and the promoter elements of the target gene. 
1.5 Phasic Activity of the Uterus 
 Despite the importance of hormones in regulating MSMC activity, uterine contractions are 
myogenic, and occur in the absence of nervous or hormonal stimuli.  In fact, strips of dissected 
uterine tissue can produce spontaneous, rhythmic contractions in an in vitro setting.  The 
observation that rhythmic uterine contractions occur spontaneously has lead researchers to 
hypothesize that there may be a uterine pacemaker stimulating rhythmic electrical activity.  
Typical biological pacemakers function by generating a current that slowly depolarizes the cell 
membrane to its threshold potential, thus culminating in an action potential.  When this slow 
depolarization occurs at a constant rate, then action potentials, and therefore contractions, are 
produced in regularly spaced intervals.  This electrical waveform is termed a ‘pacemaker 
potential’.  Sharp electrode recordings of human, mouse, and rat uterine tissue have all 
demonstrated the presence of a pacemaker potential in uterine tissue from different regions of the 
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uterus (59-61).  Both in vitro and in vivo experiments have shown that electrical activity can 
initiate from any region in the uterus, further diminishing the notion that there is a central 
pacemaking node (62-64).  Although cells similar to interstitital cells of Cajal (the cells which 
drive pacemaking in the gut) have been identified in the human and rodent myometrium, the 
evidence does not strongly support a role for these cells in uterine pacemaking (65-68).  This has 
lead to the notion that all myometrial smooth muscle cells have the capacity to drive pacemaking 
activity.  The identity of the proteins, presumably ion channels, involved remains to be 
identified. 
1.6 Ion Channels in the Myometrium 
 There has long been interest in the specific mechanisms regulating uterine electrical 
activity.  Studies in the late 1950s and 1960s assessed the shape, duration, ionic content, and 
endogenous agonists of uterine action potentials (59, 69-74).  As pharmacology, 
electrophysiology, and molecular biology techniques advanced in the 1980s specific currents 
were identified.  For example, in 1987 Boyle et al published a study in which patch-clamp 
experiments were performed on Xenopus oocytes injected with RNA extracts from estrus-staged 
or pregnancy-staged rat uterus (75).  They found that in different hormonal milieus, the total 
mRNA pool contained different levels of K+-channel transcripts, as measured by gain and loss of 
K+-channel currents.  A year later, Wilde and Marshall demonstrated that the broad K+-channel 
blockers, tetraethylammonium chloride and 4-aminopyridine, could extend the duration of action 
potential bursts in rat uterine circular muscle (76).  These types of studies lead to our broad 
understanding of how uterine excitability is regulated.  In the 1990s, the genetic identities of 
many of the ion channels contributing to the currents in the myometrium and elsewhere were 
revealed by improved cloning techniques.  This lead to candidate gene approaches, from which 
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uterine physiologists have gradually added to the list of ion channels present in the myometrium.  
More recently, RNAseq was applied to human uterine tissue to identify changes in the 
transcriptome between human myometrium samples of pregnant, non-laboring and laboring 
women (77).  This study and others revealed that the myometrium expresses more than thirty 
different ion channels (77, 78).  The wide variety of ion channels expressed in the myometrium 
likely provides functional redundancy, creates a more robust system, and allows fine-tuning of 
myometrial electrical signaling across regions of the uterus and throughout the reproductive life 
cycle. 
1.7 The Role for Na+ in MSMCs 
 Unlike many other excitable cells such as neurons where Na+, conducted by fast, voltage-
gated channels, is the main ion responsible for the the depolarizing upstroke of an action 
potential, the MSMC action potential upstroke is produced mainly by Ca2+ currents (29, 79).  
While there have been some reports of tetrodotoxin (TTX)-sensitive, fast Na+ currents in rodent 
myometrial smooth muscle cells (80, 81), there have been additional reports citing no dampening 
of uterine excitability by TTX (82, 83). Although voltage-gated Na+ channel transcripts have 
been observed (77), there have also been no observations of a TTX-sensitive current in human 
MSMCs.  However, many studies have reported that the pattern of myometrial action potentials 
relies on Na+ flux.  Anderson et al. reported that the regenerative properties of estrogen-treated, 
non-pregnant rat myometrial action potentials relied on the presence of both Na+ and Ca2+, and 
that removal of Ca2+ from the extracellular solution increased the inward leak current in these 
cells (84, 85).  Kleinhaus et al also demonstrated that in pregnant rabbit myometrium, bursting 
activity initially stopped when extracellular Na+ was replaced by a non-permeable cation, and 
then recovered with sustained bursting (59). Anderson and Moore also demonstrated that Na+-
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free solution reduced a transient inward current in the estrogen treated rat myometrium.  These 
studies along with others (86) suggest that there is a subtle role for Na+ in regulating myometrial 
excitability.  More recently Myoshi et al. reported the presence of a Na+-dependent, Gd3+-
sensitive leak current in rat MSMCs that was hypothesized to contribute to uterine excitability 
(87).  We identified the presence of a similar current in human MSMCs that was, in part, 
dependent on the expression of a Na+-leak channel, called NALCN (See chapter 2). 
1.8 Na+-Leak Channel, Non-Selective (NALCN) 
1.8.1 NALCN in Regulating Resting Membrane Potential  
Most excitable cells maintain their resting membrane potential (RMP) between -80 mV 
and -50 mV, closer to the reversal potential of K+ (-86 mV) than those of Na+ or Ca2+ (+84 mV 
and +127 mV, respectively).  Because of this, it has been well accepted that the background K+ 
conductance is the primary regulator of the RMP.  However, the reversal potential of K+ (-86 mV 
based on a concentration of 5 mM [K+]out  and 140 mM [K+]in) is more negative than the typical 
resting membrane potential of MSMCs (-55 mV).  This suggests that the RMP must also depend 
on other background currents, such as a Na+ leak current.  By letting small amounts of Na+ into a 
cell, a Na+-leak current can counteract the hyperpolarizing contribution of background K+ 
currents.  One particular ion channel that has been shown to function in this way is the Na+-leak 
channel, non-selective (NALCN).   
NALCN was named in 2007 by Boxun Lu in Dejian Ren’s group after its ability to 
conduct a constitutively active, cationic leak current (88).  This channel, which is a member of 
the 4x6 transmembrane domain (TMD) family of channels that includes voltage gated Na+ (Nav) 
and Ca2+ (Cav) channels, was found to be voltage insensitive (88).  Voltage sensitivity is 
conferred by the charged residues of the S4 segment of each domain, which in NALCN are 
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reduced from 21 to 14 (88).  Also in 4x6 TMD channels, ion selectivity is determined by an 
amino acid motif composed of one amino acid contributed from the pore-forming loop of each 
transmembrane domain.  While Nav channels have a DEKA motif, and Cav channels have a 
EEEE motif, NALCN’s selectivity filter motif is EEKE, a unique fusion of the other two, which 
gives it a non-selective pore (Fig 1.3) (88).  NALCN conducts Na+ (relative permeability (P) = 
1.3), K+ (P = 1.2), Cs+ (P = 1.0) and, to a lesser extent, Ca2+ (P = 0.5) (88).  The NALCN current 
(INALCN) was found to be constitutively active, insensitive to inhibition by tetrodotoxin, and 
sensitive to inhibition by Gd3+, Cd2+, Co2+, and verapamil (88).  Although NALCN can conduct 
both Na+ and K+, at the RMP the driving force for Na+ into the cell is greater than that for K+, 
making NALCN primarily a Na+-conducting channel.   As was hypothesized based on its 
constitutive Na+ conductance, NALCN has been shown to be an important modulator of RMP in 
cell types including neurons and pancreatic beta cells (88-93).  
1.8.2 NALCN Discovery 
NALCN, originally called Vgcnl1, was cloned from the rat in 1999, by J.H. Lee et al (94, 
95).  Based on analysis of its hydropathy plot and protein sequence homology to other ion 
channels NALCN was hypothesized to be a cation channel (95).  Homologs of this channel have 
been identified in vertebrates and invertebrates, including yeast (96).  As such, some of the first 
studies of NALCN were done in the invertebrate nematode, C. elegans, and the fruit fly, D. 
melanogaster.  Since its original discovery, studies of NALCN have gone on to reveal a 
widespread role for this channel in biological rhythms, ranging from the rapid respiratory rhythm 
of a mouse (seconds) (88), to the slower circadian rhythms of the fly (~24 hrs) (97).  
Additionally, researchers have found that this channel does not work in isolation, but that it 
associates with a complex of proteins including UNC79, UNC80, and NLF-1, and can be 
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regulated by several G-protein coupled receptors. 
1.8.3 NALCN in Regulating Neuronal Excitability 
Much of the early research done on NALCN has been in the context of the nervous 
system and NALCN’s role in regulating spontaneous and rhythmic neuronal firing.  Learning the 
function of NALCN in the nervous system provides a useful framework for understanding its 
function in other excitable tissues, like the myometrium. The foundational works that have 
established NALCN’s role in excitability were done in three different animal models: Mus 
musculus, Caenorhabditis elegans, and Drosophila melanogaster. 
Studies in C. elegans identified the NALCN homologs nca-1 and nca-2 through forward 
genetic screens assessing important genes for the characteristic sinusoidal locomotion pattern of 
the worm.  Nca loss-of-function (nca(lf)) mutants display a ‘fainter’ phenotype in which the 
worm repeatedly paused as it attempted to move across the petri plate (98).  Conversely, nca-1 or 
nca-2 gain of function mutants (nca(gf)) displayed a ‘coiler’ phenotype in which they showed 
uncoordinated and exaggerated bending behavior that resulted in a coiling motion (98).  In vivo 
Ca2+-imaging experiments of the hermaphrodite specific neurons (HSN) in nca(lf) worms 
showed normal Ca2+-spikes at the neuron cell body, but reduced spike frequency and amplitude 
in the pre-synaptic area (98). The nca(gf) mutants similarly showed normal Ca2+-spikes at the 
cell body, but had increased spike amplitude at the presynaptic area (98).  In the C. elegans 
nervous system, which lacks voltage-gated Na+ channels, nca seems to be playing an important 
role in transmitting the depolarization signal from the cell body, down the length of the synapse.  
Supporting this hypothesis, nca(lf) mutants had decreased miniature post-synaptic currents at the 
neuromuscular junction (90).  
In the initial reverse genetics studies in the fly, mutations of NALCN or NA as its called in 
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D. melanogaster, caused a narrow abdomen (NA) phenotype and hypersensitivity to the volatile 
anesthetic halothane (99, 100). Beyond a narrow abdomen phenotype, they also had disrupted 
circadian regulation of their locomotion behavior.  Specifically, na mutant flies had lost the 
increase in activity at dawn, and the light-dark transition anticipation behavior characteristic of 
WT flies (95).   Immunofluorescent staining of fly brains showed that NA was expressed in 
circadian pacemaker neurons (97).  Normal circadian behavior was rescued by the reintroduction 
of na to these select neurons, and it was suggested that NA mediated this activity through 
conducting an inward cation current.  Importantly, the mutation of NA did not disrupt normal 
cycling of clock genes like PERIOD, suggesting that NA may be a downstream target of the 
clock genes (97).  Greatly expanding on this work, Flourakis et al showed that NA is indeed 
working through modulation of the RMP of circadian pacemaker neurons, and mutations of NA 
result in a significantly reduced firing rate of these neurons (91).  They found that while na levels 
remained constant across the 24 hr light:dark period, its activity was being rhythmically altered 
by a chaperone protein of NA called NLF-1 (see section on NALCN complex partners).  In fact, 
NLF-1 mRNA levels were increased during the day, thereby allowing greater activity of NA at 
the cell membrane.  They expanded upon their findings by creating an NALCN forebrain 
specific knockout mouse, and found that the neurons of the suprachiasmatic nucleus (the central 
clock) showed a similar dependence on NALCN for regulating spontaneous firing and RMP.  
They proposed a ‘bicycle model’ in which depolarizing NA currents drive excitability of 
circadian pacemaker neurons during the day, and hyperpolarizing K+ currents silence firing at 
night.  This work was important in demonstrating how an ion channel like NALCN which can 
stimulate rapid firing in neurons, can also affect slower biological rhythms by regulation of its 
cell surface expression. 
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Finally, key studies in the murine model have begun to establish the role of NALCN in 
mammalian neurophysiology and played an important part in garnering interest in the study of 
NALCN. Boxun Lu and colleagues described the phenotype of the global NALCN knockout 
mouse in 2007 (88).  These mice were found to die within 24 hours of birth due to disrupted 
respiratory rhythm wherein they experienced repeated episodes of apnea (arrested breathing for 
more than 3 seconds).  This phenotype was linked to reduced spontaneous firing of the fourth 
cervical nerve root, which innervates the diaphragm, indicating a role for NALCN in 
spontaneous neuronal firing.  NALCN was also found to be expressed in the hippocampus, and 
comparisons between membrane potential of neonatal hippocampal neurons showed that 
NALCN KO mice had a more hyperpolarized RMP (-70 mV) compared to WT (-60 mV).  
Hyperpolarization of the membrane potential reduced the spontaneous firing rate of these 
neurons, such that +50 pA of exogenous current needed to be injected into the cells to achieve 
similar firing rates as WT neurons.  This landmark paper demonstrated the significant role for 
NALCN in modulating RMP and excitability of mammalian neurons, and the profound effect 
that this could have on physiology.  More recently, Gary Yellen’s group expanded on this work 
by showing that NALCN contributes to the firing rate of substantia nigra pars reticulata neurons 
(92).  Together, studies by these labs and others have shown that NALCN can contribute to basal 
firing rates as well as agonist enhanced firing rates (discussed below).   
1.8.4 NALCN Complex 
 Shortly after its discovery, researchers discovered that NALCN does not work in 
isolation, but rather interacts with a complex of proteins that help it carry out its function.  In 
studying the C. elegans nca-1/2 mutants, Yeh et al. recognized that two previously described C. 




Figure 1.3 The NALCN complex.   
A)  NALCN has four homologous repeats (I – IV) each containing six transmembrane domains (S1 – S6). 
The S4 domains contain 14 positively charged residues compared to the 21 charged residues in Cav and 
Nav channels.  The pore motif in NALCN is EEKE, with residues interacting from the in the S5-S6 loop 
regions of each repeat. B) NALCN is transported to the plasma membrane with the help of the ER-
resident protein, NCA localizatin factor 1 (NLF-1).  At the plasma membrane, NALCN can interact with 
G-protein coupled receptors (GPCRs) including Tachykinin receptor 1 (TACR1) and Muscarinic receptor 
3 (M3R).  When stimulated by their agonists, substance P and acetylcholine, respectively, they can 
enhance NALCN currents through a Src-family kinase (SFK) dependent pathway.  These processes 
require the presence of the scaffolding proteins UNC80 and UNC79.  NALCN can also be inhibited by 
the calcium sensing receptor (CaSR), another GPCR.  CaSR signals through its G-protein to inhibit 
NALCN under normal (2 mM) Ca2+ concentrations.
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mutant (98). Crossing unc80 and nca(lf) resulted in worms with the same fainter phenotype as 
the single mutants, and crossing unc80 with the nca(gf) coiler mutant eliminated the coiler 
phenotype and produced only worms with the loss of function ‘fainter’ phenotype, indicating a 
dependence of NCA on UNC80.  Through further study they found that UNC79 and UNC80 co-
localized with NCA-1, and that each of the three proteins is required for the localization of the 
others to the axon. Later work by Dejian Ren’s lab showed that NALCN drives the substance P 
(SP) induced current (ISP) in mouse hippocampal neurons, and that in HEK293T cells, this 
stimulated current requires the expression of UNC80 and the tachykinin receptor (TACR1) 
(101).  Interestingly, though TACR1 is a Gq G-protein coupled receptor (GPCR), ISP was 
unaffected by the presence of the non-hydrolyzable forms of GTP (GTP-γ-S) and GDP (GDP-β-
S), indicating a signaling mechanism independent of classic GPCR signaling.  However, ISP was 
inactivated by Src-family kinase inhibitors PP1 and genistein, implicating SFK-dependent 
phosphorylation of NALCN and UNC80 as the mechanism of ISP activation.  Additional studies 
in the Ren lab suggest that UNC80 serves as a scaffolding protein for NALCN, recruiting Src to 
the channel complex (102).   
In addition to TACR1, other GPCRs have been shown to modulate the NALCN current 
(INALCN). The neurotensin receptor and the muscarinic receptor 3 (M3R) were found to activate 
INALCN upon binding of their ligands, neurotensin and acetylcholine, in a manner similar to 
TACR1 and SP (89).  Conversely, the calcium sensing receptor (CaSR) was found to have an 
inhibitory effect on INALCN under normal extracellular calcium concentrations (103).  Upon 
reduction of extracellular calcium from 2 mM to 0.1 mM, NALCN currents more than tripled in 
size, and this effect was synergistic with the activation caused by SP.  The low calcium 
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activation of NALCN was found to be the result of removal of a constant inhibition of NALCN 
by the CASR, and this was found to be G-protein dependent as was evidenced by loss of the 
current under low calcium conditions when CASR activity was sustained by GTP-γ-S (103). 
One last component of the NALCN complex was again originally identified in C. 
elegans, and because it was shown to be essential for the proper localization of NALCN to the 
plasma membrane, it was given the name NCA localization factor-1 (NLF-1) (104).  NLF-1 
mutants have the same fainter phenotype as the unc80, unc79, and nca(lf) mutants.  However, 
unlike UNC79 and UNC80, NLF-1 contains an ER-retention motif and does not co-localize with 
the rest of the complex at the cell surface, but is nonetheless essential for the trafficking of the 
complex.  As previously mentioned, NLF-1 plays an important role in the SCN in regulating the 
day/night trafficking of NALCN to the plasma membrane of the pacemaker neurons (91).  This 
novel mechanism of temporally regulating NALCN activity could play an important role in other 
tissues where excitability is strategically modulated over time or upon environmental changes.  
1.8.5 Human Mutations of NALCN 
Since 2013, several mutations of NALCN have been found as driver mutations in 
children with differing arrays of neurologic and developmental defects.  Four recessive 
mutations of NALCN have been found in children of different consanguineous families.  Three 
of the recessive mutations result in truncated proteins by creating premature stop codons at 
different locations in the NALCN protein: 1) between S3 and S4 of domain II, 2) between II-III 
linker region, and 3) within the pore region of homologous repeat III.  The remaining recessive 
NALCN mutation results in a missense mutation (W1287L) in S3 of domain IV (105).  Although 
it is expected that these truncating mutations cause loss of function of the channel, the effect of 
the W1287L mutation has not been studied in further detail.  The children with these mutations 
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have many overlapping traits including facial dysmorphisms, intellectual disability, and 
hypotonia.  Some of the children also present with speech impairment, chronic constipation, 
cachexia, strabismus, and abnormal respiratory rhythm (106-108).  As a group these children are 
classified as having infantile hypotonia with psychomotor retardation and characteristic facies 
(IHPRF).  Additionally, many de novo NALCN mutations have been discovered in children with 
some similar traits including hypotonia, facial dysmorphisms, and developmental delay.  
However, many of the patients with heterozygous, de novo mutations also presented with 
arthrogryposis (contractures of the joints) as well as congenital contractures of the face, and 
individual patients presented with ataxia, hyperthermia, and central hypertonia (105, 109-111).  
These patients are classified as having congenital contractures of the limbs and face with 
hypotonia and developmental delay (CLIFHADD).  All of the de novo mutations discovered 
have been missense mutations and are primarily located in the pore forming regions of the 
channel.  Only three of the mutations have been studied in vitro.  Y587S (S6 of domain II) and 
L509S (S4-S5 linker of domain II) were found to inhibit expression of the WT channel when 
cotransfected in HEK293T cells.  Additionally, R1181Q, found in two separate studies, when 
introduced into C. elegans produced a coiler phenotype, indicating that it may create a gain of 
function mutation.  A recent study examined the effect of several of the de novo, autosomal 
dominant mutations on C. elegans locomotion (112).  Many of these mutations produced the 
gain-of-function coiler phenotype, while others appeared to function as dominant negative 
‘fainters.’  Although it is confusing that patients with dominant negative and gain-of-function 
mutations have similar features, the authors argue that this could be the result of differential 
effects in inhibitory and excitatory neuronal circuits.  Importantly, these mutations demonstrate 
the crucial role of NALCN at neuromuscular junctions, and in normal neurologic function and 
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development.  Interestingly, the good health of parents with one copy of the NALCN recessive 
mutations (primarily truncating), suggests that only one normal copy of NALCN is needed.  
However, the effect of the de novo heterozygous mutations suggests that particular mutations can 
negate the presence of a normal copy.   
  Recently, several UNC80 mutations have also been discovered (113-115).  All of these 
mutations are recessive, and include both truncating and missense mutations.  These patients 
have some similar traits to those with NALCN mutations, including hypotonia and intellectual 
disability, and also have unique traits including encephalopathy, growth failure, and one 
experienced intrauterine growth restriction.  Again, the function of these mutations has not been 
studied in great detail. 
1.8.6 Other Functions of NALCN 
 In addition to the extensive work examining the function of NALCN in the nervous 
system, there have been a few studies linking NALCN to other excitable tissues, such as the 
pancreas and interstitial cells of cajal (ICCs), and in osmoregulation.  In the murine pancreatic 
beta cell line, MIN6 cells, NALCN was found to associate with M3R and be activated by 
acetylcholine through an SFK-dependent pathway (89).  Further studies assessing the importance 
of NALCN in pancreatic function and insulin release have not been published, but it is 
hypothesized that NALCN would be an important factor in depolarizing beta cells to initiate 
insulin release.  Additionally, NALCN was found to be expressed in cultured murine ICCs, cells 
that are important for stimulating the rhythmic peristalsis of the intestinal smooth muscle (116).  
These cells show increased firing and the induction of an inward leak current upon the addition 
of substance P.  ICCs from NALCN knockout mice showed a reduction in the SP-induced leak 
current and a dampened SP-induced firing rate, indicating that NALCN may play an important 
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role in enteric responses.  Finally, NALCN has been linked to osmoregulation in mice (117).  In 
fact, heterozygous NALCN knockout mice have significantly higher serum Na+ concentrations 
(149 mM in NALCN KO compared to 146 mM in WT).  These studies point to the broad 
importance of NALCN as a modulator of membrane excitability, and the likely possibility for 
new discoveries of NALCN functioning in many different tissue types.  
1.9 The Role of NALCN in Uterine Physiology 
 In my thesis work, I examined the presence and role of NALCN in MSMC excitability 
and in parturition outcomes.  First, I demonstrated that NALCN is expressed in human MSMCs, 
and that it conducts a Na+-dependent, Gd3+-sensitive leak current in these cells.  I went on to 
show that NALCN is also expressed in the mouse myometrium, and that it is essential for 
successful parturition.  I created an NALCN smooth muscle specific knockout mouse line 
(smNALCN-/-), which within the reproductive tract, primarily deletes NALCN from the 
myometrium.  These mice show an increased prevalence of prolonged or dysfunctional labor, 
and reduced uterine excitability exemplified by a shortened myometrial burst duration.  Finally, I 
have found that NALCN is regulated by progesterone and shows regional expression differences.  
The protein levels of NALCN inversely correlate with circulating progesterone levels in the 
mouse, and the addition of exogenous progesterone at term keeps NALCN levels low.  
Progesterone also enhances the expression of a potential novel isoform of NALCN.  This work 
has identified NALCN as an important player in uterine physiology and builds the foundation for 
further study of the mechanism of NALCN function in parturition.  
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2.1 Introduction 
Regulation of uterine contractile frequency and intensity is essential for several functions 
of the female reproductive tract, including implantation of the embryo, transport of sperm for 
fertilization, and formation of contractile waves associated with the menstrual cycle (1). Most 
notably, the contractile state of the uterus must be tightly regulated throughout pregnancy; the 
uterus must remain quiescent during pregnancy to foster growth of the fetus, become activated at 
term to produce forceful, coordinated, and rhythmic contractions to deliver the infant, and finally 
involute to return to its pre-pregnancy state.   
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The myometrial smooth muscle cell (MSMC) action potential underlies control of uterine 
contractions, with the phasic and regenerative depolarization and repolarization of the MSMC 
membrane resulting in rhythmic, spontaneous contractions.  The depolarizing upstroke is 
predominantly due to Ca2+ influx, which is modulated, in large part, by activation of L-type 
calcium channels.  The roles of Ca2+ in mediating the membrane potential and providing a 
contractile signal for electromechanical coupling have been well characterized (2).  Recent 
evidence has revealed that a large milieu of ion channels underlie the electrical activity of 
MSMCs (3), indicating the complexity of signals that must function coordinately to keep 
MSMCs in a pro- or anti-contractile state.  However, the currents that depolarize the membrane 
to the extent required for L-type calcium channel activation have not been fully elucidated. 
An important contributor to cell excitability is the action of a non-selective cationic leak 
current, defined as a non-gated, or constitutively active, flow of cations across the cell membrane 
with a reversal potential nearing 0 mV under physiological ion concentrations.  For example, in 
the sinoatrial node of the heart, the inwardly rectifying K+ channels and the hyperpolarization-
activated ‘funny’ current provide a coordinated leak of cations into cardiomyocytes to produce 
pacemaker activity (4-6).  Similarly, the rhythmic firing of dopaminergic neurons of the ventral 
tegmental area of the brain is modulated by a tetrodotoxin-insensitive Na+-leak current (7).   
Working with rat MSMCs, Miyoshi et al. (8) observed a leak current that displayed a 
Na+-dependent conductance and was sensitive to inhibition by the trivalent cation gadolinium 
(Gd3+) (IC50 of 3.0 µM).  No such leak current has yet been identified in the human myometrium.  
Furthermore, the specific ion channels that drive this current remain to be identified.  RNA 
sequencing data from human myometrial tissue revealed the expression of a channel with leak-
distinctive features, the Na+ leak channel, non-selective (NALCN) (3).  This channel is a 
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member of the 4x6 transmembrane domain family, which includes voltage-gated Ca2+ and 
voltage-gated Na+ channels (9-11).  Studies of NALCN in heterologous expression systems, 
mice, C. elegans, L. stagnalis, and D. melanogaster nervous systems have demonstrated that, 
unlike other members of its family, NALCN is voltage-insensitive and contains a non-selective 
pore domain, allowing it to conduct Na+, Ca2+, K+, and Cs+ (9, 12-15).  In addition to its 
canonical form, NALCN has several alternatively spliced isoforms with undescribed functions 
(15, 16).  NALCN is sensitive to inhibition by Gd3+ (IC50 of 1.4 µM) (9, 17, 18) and has 
properties similar to the current described in the rat myometrium (8).  
By conducting a leak current, NALCN has a profound effect on excitable cells.  NALCN 
mediates the slow influx of Na+ into the cell, bringing the resting membrane potential closer to 
the threshold for action potential generation (9, 12, 14).  This characteristic allows it to drive 
rhythmic processes including respiratory rhythm, gastro-intestinal contractility, and circadian 
behavior (9, 13, 19), making it a strong candidate for the regulation of uterine activity.  On the 
basis of evidence that NALCN mRNA is expressed in the human myometrium and its role in 
conducting an excitatory leak current in multiple rhythmic cell types, we hypothesized that the 
NALCN channel is expressed in the human myometrium and contributes to a cationic leak 
current in MSMCs.  We addressed our hypothesis by using electrophysiology and RNAi 
technology in freshly isolated and cultured MSMCs from pregnant women at term.  We report 
that human MSMCs have a Na+-dependent, Gd3+-sensitive leak current that is dependent on 
NALCN expression.  The discovery of NALCN expression and activity in the myometrium has 




2.2 Materials and Methods 
2.2.1 Ethical Approval and Acquisition of Human Samples 
 Human myometrial tissue from the lower uterine segment was obtained from 23 non-
laboring women who underwent Cesarean hysterotomy under regional anesthesia in late 
pregnancy (term non-labor [TNL]; 37-40 weeks of gestation). The indications for Cesarean were 
placenta previa (1 woman), non-reassuring fetal status (1), breech presentation (1), previous 
delivery with shoulder dystocia (2), hip replacement (1), and previous Cesarean section (17).  
None of the women reported having contractions, and no contraction-altering drugs were given. 
Before the procedure, a clinical research nurse coordinator in the Department of Obstetrics and 
Gynecology at Washington University School of Medicine explained details of the biopsy 
procedure to the subjects and obtained signed written consent forms approved by the Washington 
University in St. Louis Human Research Protection Office (IRB 201108143).  The subject 
population was approximately 50% African American and 50% Caucasian. Nine of the 23 
women reported an underlying health problem(s), including mental illness (3 women, 1 of whom 
was taking medication), hypotension (1), gestational hypertension (1), history of syncopal 
episode (1), Bell’s Palsy (1), morbid obesity (1), rheumatoid arthritis (1), and an ovarian cyst (1).  
Additionally, one woman’s fetus was large for gestational age, and another woman’s fetus 
presented with intrauterine growth restriction.  None of the data acquired from samples from 
women with underlying disease was outside the normal range, and analysis was done blinded to 
underlying conditions. Samples were stored in ice-cold phosphate buffered saline (PBS) and 
processed for explant expansion and smooth muscle cell isolation within 90 min of acquisition.  
Samples used for RNA extraction were collected in RNAlater® (Ambion, Austin, TX, USA) and 
stored at -20°C within 30 min of acquisition. Samples used for membrane preparations were 
flash frozen in liquid nitrogen and stored at -80°C within 90 minutes of acquisition.  Samples 
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obtained from at least three women were used for each experiment. 
2.2.2 Cell Isolation  
 Freshly isolated human myometrial smooth muscle cells (hMSMCs) were isolated from 
myometrial samples according to previously described methods (20) with minor modifications.  
Briefly, samples were cut into pieces ~2 – 4 mm2 and digested with 1 mg/ml collagenase IA 
(Sigma, St. Louis, MO, USA) and 1 mg/ml collagenase XI (Sigma) in DMEM F-12 media (Ref. 
11039, Gibco, Grand Island, NY, USA) containing 0.1% BSA (Sigma) and 25 µg/ml gentamicin 
(Gibco) for 40 min at 37°C.  Digested tissue was strained through a 40-µm cell strainer, washed 
twice with DMEM F-12 containing 10% FBS (Ref. 26140, Gibco) and 25 µg/ml gentamicin 
(standard media), and then plated onto a six-well plate in DMEM F-12 containing 5% FBS and 
25 µg/ml gentamicin.  Freshly isolated cells were used within 3 and 22 hours after tissue biopsy. 
 Cultured hMSMCs from TNL explants were expanded within 2 h of biopsy in DMEM F-
12 medium supplemented with 5% FBS, 2 ng/ml basic fibroblast growth factor (Lonza, 
Allendale, NJ, USA), 3 ng/ml epithelial growth factor (Lonza), 25 µg/ml gentamicin, 5 µg/ml 
fungizone (Gibco), and 5 µg/ml insulin (Sigma).  Cells were maintained in standard media and 
used at passage four.  Immunoblotting confirmed that NALCN expression was maintained 
through this passage.  Quantitative RT-PCR showed that NALCN expression was higher in 
passage four than in passage one.   
2.2.3 Electrophysiology 
 Cells were plated directly or trypsinized and transferred to glass coverslips, and 
electrophysiological measurements were made within 4 h.  Cultured hMSMCs were serum 
starved in 0.5% FBS-containing media for 20 – 24 h before electrophysiology experiments were 
performed.  Glass pipettes were pulled and polished to 2.5 – 5 MΩ and filled with a pipette 
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solution containing 125 mM Cs-Aspartate, 20 mM tetraethylammonium (TEA)-Cl, 5 mM Mg-
ATP, 5 mM EGTA, 100 nM free Ca2+ (calculated with Maxchelator software [Stanford 
University]), and 10 mM HEPES, pH 7.2. Currents were measured in an extracellular bath 
solution containing: 125 mM NaCl or N-methyl-D-glucamine (NMDG), 20 mM TEA-Cl, 0.1 
mM MgCl2, 5 mM HEPES, 11 mM glucose, 1 µM CaCl2, and 5 µM nifedipine, pH 7.4.  K+ was 
replaced with Cs+.  TEA-Cl  and nifedipine were added to the bath solution to isolate the leak 
current by blocking voltage-gated K+ and Ca2+ channels, respectively. Leak currents were 
recorded at a sampling rate of 10 kHz and filtered at 1 kHz by using an Axopatch 200B amplifier 
(Molecular Devices, Sunnyvale, CA, USA).  Cells were held at 0 mV and currents were elicited 
by stepping from -55 mV (50 ms) to +40 mV for 100 ms (to inactivate voltage-gated Ca2+ and K+ 
channels) followed by 20 mV steps (500 ms) from -100 mV to +100 mV using the pClamp 10 
software (Molecular Devices). Currents were normalized to cell capacitance, and the mean and 
standard error of the mean (SEM) of the current density were calculated for each group of 
samples.  Normalized conductance was determined by calculating the slope of the linear 
regression for currents elicited by voltages between -100 mV and -20 mV, as this was the most 
linear part of the currents.  Reversal potentials were similarly determined by calculating the X-
intercept of the linear regressions and calculating the mean ± SEM.   
2.2.4 RNA Isolation and RT-PCR 
 Total RNA was isolated from myometrial biopsies by using the Aurum Total RNA Fatty 
and Fibrous Tissue Pack Kit (BioRad, Hercules, CA, USA) and reverse transcribed to generate 
cDNA by using the iScript cDNA Synthesis Kit (BioRad) according to the manufacturer’s 
instructions.  cDNA was stored at -20°C until PCR was performed.  Forty-cycle PCR was 
performed on cDNA by using Taq PCR Master Mix (2X) (Affymetrix, Santa Clara, CA, USA) 
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and primers (Table I) specific to NALCN, UNC80, UNC79, or NLF-1 (Integrated DNA 
Technologies, Coralville, IA, USA).  Products were electrophoresed on a 1.5% agarose gel.  
2.2.5 RNAi Lentiviral Transduction 
 Replication-deficient lentiviruses were packaged by the England lab or by the HOPE 
Center Viral Vectors Core at Washington University in St. Louis.  The lentiviral vector, 
pLVTHM, was a gift from Arnaud Monteil (18).  The encoded shRNA target sequences were 
designed by an Ambion algorithm to be specific to NALCN and have no more than 70% 
coverage with any other part of the human transcriptome.  The target sequences are reported in 
Table I.  hMSMCs were incubated with half the normal flask volume (6 ml for a T-75, 1 ml for a 
6-well plate) of standard media containing 8 µg/ml polybrene for 10-15 min before adding viral 
particles. Transductions took place over 16 h, after which media was replaced with standard 
media.  Only cells expressing GFP (co-expressed by the viral vector and confirmed by 
fluorescence microscopy) were used for electrophysiological measurements.  For analysis of 
knockdown, an MOI that generated 85% – 95% GFP-positive cells (confirmed by flow 
cytometry 48 h after transduction) was used. Cells were used 6-8 days post-transduction for 






2.2.6 Quantitative RT-PCR 
 RNA was extracted from stored human myometrial tissue, or hMSMCs 6-9 days after 
transduction with lentiviral vectors.  RNA quality was ensured by gel electrophoresis analysis 
and 260/280 nm and 260/230 nm absorbance ratios above 1.8 and 2.0, respectively. qRT-PCR 
reactions (20 µl) contained 5 pmol of each forward and reverse primer (Table I), cDNA 
produced from 50 ng of RNA, and iQ SYBR Green Supermix (BioRad). Gene targets were 
amplified and quantified by the CFX96 BioRad Real-Time PCR Detection System.  The 
temperature cycles were as follows:  95°C for 3 min (1X), and 95°C for 10s followed by 57°C 
for 30s (40X), ending with a 0.5°C increment melt curve from 65°C to 95°C.  Primer efficiencies 
were ≥ 77% with human brain cDNA, and the calculated efficiency values were used in Pfaffl 
analysis of relative gene expression (21).  Target gene expression was normalized to the 
reference genes topoisomerase I (TOP1) and succinate dehydrogenase complex, subunit A 
(SDHA), chosen because of their consistency of expression in the myometrium across pregnancy 
(22).    
2.2.7 Immunoblot 
 For lysis of cultured hMSMCs, media was aspirated from the cells, and they were washed 
with cold DPBS.  Cells were then scraped into ice-cold lysis buffer containing: 10 mM Tris-Cl, 
150 mM NaCl, 1% Triton X-100, and a Complete Mini Protease Inhibitor Cocktail pellet 
(EDTA-free, Roche Molecular Biochemicals, Indianapolis, IN, USA), pH 8.0. Cells were then 
homogenized with 0.1-mm glass beads by using the Next Advance Bullet Blender (Averill Park, 
NY, USA).  Homogenates were separated by centrifugation at 9,000 g for 20 min at 4°C.  For 
preparation of human myometrium cell membranes, flash frozen tissue was finely chopped and 
then homogenized by a Tekmar Tissumizer (Cincinnati, OH) in membrane preparation solution 
containing: 250 mM sucrose, 50 mM MOPS, 2 mM EDTA, 2 mM EGTA, pH7.4, 1 mM PMSF, 
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and a Complete Mini Protease Inhibitor Cocktail pellet (EDTA-free).  Non-homogenized tissue 
was removed by centrifugation at 14,000 g for 15 min.  Cell membranes were isolated from the 
supernatant by ultracentrifugation at 100,000 g for 1 h.  Membrane pellets were dissolved in lysis 
buffer for 2 h.  Any remaining insoluble components were removed by centrifugation at 9,000 g 
for 20 min.   All steps were performed at 4°C with ice-cold buffers to prevent proteins from 
degrading.   
 Protein concentrations of whole cell lysates and membrane preparations were measured 
by using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL, USA). Protein samples 
were mixed with Laemmli sample buffer, heated to 65°C for 15 min, and stored at -20°C. Protein 
samples (40 µg for myometrium, and 10 µg for mouse brain) were separated by SDS-PAGE and 
transferred to a nitrocellulose membrane. After blocking in PBS containing 0.075% Tween-20 
(PBST) and 5% milk, membranes were probed with the following primary antibodies: anti-
NALCN N-20 (1:500; Santa Cruz Biotechnologies, Inc., Santa Cruz, CA, USA) in the presence 
or absence of the NALCN N20 antigenic peptide (1 µg/ml), anti-GAPDH (1:1000; Millipore, 
Billerica, MA, USA), or anti-transferrin receptor (1:500; Invitrogen, Camarillo, CA, USA). Blots 
were then probed with HRP-conjugated secondary antibodies (1:4000; Jackson ImmunoResearch 
Laboratory Inc., West Grove, PA, USA) in PBST containing 3% milk.  Signal was detected with 
Clarity ECL Western chemiluminescence (BioRad).  NALCN expression was normalized to 
GAPDH by using ImageJ densitometry, and values from shNALCN-treated cells were compared 
to those from shScr-treated cells. 
2.2.8 Statistical Analysis 
 All data are presented as mean ± SEM. Statistical significance was determined by one-
tailed Student’s t-test (two groups), one- or two-way ANOVA (three or more groups) correcting 
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for multiple comparisons by using GraphPad Prism 6 (San Diego, CA, USA), and P < 0.05 was 
considered significant.  N refers to number of cells, and n refers to the number of patient samples 
tested.   
2.3 Results 
2.3.1 The Na+-dependent, Gd3+-sensitive Leak Current in hMSMCs 
To determine whether a leak current is expressed in the human myometrium, whole-cell voltage 
clamp experiments were performed on freshly isolated human myometrial smooth muscle cells 
(hMSMCs) from uterine samples from non-laboring women who had Cesarean sections at full 
term.  An ohmic leak current with a reversal potential of 21.8 ± 9.2 mV was identified (Fig. 
2.1.A, C, and Table 2.2). Adding 10 µM Gd3+ (a concentration known to inhibit NALCN 
currents by ~80%)(Lu, et al., 2007) to the bath solution significantly reduced the average 
conductance of this current by 75% and shifted the reversal potential to +88 mV (Table 2.2), 
indicating the presence of a Gd3+-sensitive current in freshly isolated cells. Although freshly 
isolated hMSMCs are optimal for characterizing myometrial cell biology, they cannot be used 
for repeated and longer-term experiments. The same whole-cell voltage clamp experiments 
revealed that, qualitatively, cultured hMSMCs behaved like freshly isolated hMSMCs (Fig. 
2.1.B, D, and F). As in freshly isolated hMSMCs, currents elicited in cultured cells at -60 mV, 
near the resting membrane potential, were significantly inhibited by addition of Gd3+ (Fig. 2.1.E). 
To elucidate the predominant cation contributing to the current in cultured hMSMCs, Na+ 
in the bath solution was replaced with the channel-impermeable monovalent cation, NMDG.  
This reduced the conductance (Fig. 2.2.A, B, Table 2.2) to a similar extent as addition of Gd3+ 




Figure 2.1 The Gd3+-sensitive leak current in freshly isolated and cultured hMSMCs.   
A and B) Representative traces of leak current evoked from a freshly isolated hMSMC (A) and a cultured 
hMSMC (B) by using a voltage step protocol with 20 mV increments from -100 mV to +20 mV, before 
and after treatment with 10 µM Gd3+.  Capacitive currents were removed from these traces. C and D) 
Current-voltage relationships obtained from freshly isolated (C, N = 7) and cultured (D, N = 7) hMSMCs 
before (closed circles) and after (open circles) treatment with 10 µM Gd3+.  Data is presented as mean 
values ± SEM. E and F) Current density analysis from freshly isolated (E) and cultured (F) hMSMCs at -
60 mV before and after treatment with 10 µM Gd3+. Symbols represent individual cells, and connecting 





Figure 2.2 The Na+-dependent leak current in cultured hMSMCs.    
A) Current-voltage relationship observed in cultured hMSMCs superfused with bath solution containing 
125 mM Na+ (closed diamonds) and replaced with 125 mM NMDG (open diamonds) and 125 mM 
NMDG + 10 µM Gd3+ (open circles) (N = 9). Data is presented as mean values ± SEM. B) Current 
density analysis at -60 mV from voltage step protocol in A before (Na+, closed diamonds) and after 
perfusion with NMDG (open diamonds) and NMDG + Gd3+ (open circles) (N = 9).  Symbols represent 
individual cells, and connecting lines link values before and after each treatment. ** P = 0.0020.  C) 
Representative current from a cultured hMSMC clamped at -60 mV.  Na+-containing bath solution was 





large positive shift seen with Gd3+ treatment [Fig. 1D]), indicating that Na+ replacement 
significantly inhibited the inward portion of the leak current (Fig. 2.2.A). To determine the extent 
to which the leak current was active at a physiologically relevant membrane potential, currents 
were recorded while holding cultured hMSMCs at -60 mV (Fig. 2.2.C) (23).  Although Na+-
dependent current density varied noticeably between individual hMSMCs, replacement with 
NMDG resulted in a significant reduction of the average current density elicited at -60 mV (Fig. 
2.2.B and Table 2.2).  Finally, to determine the extent to which Na+ drives the Gd3+-sensitive 
current, 10 µM Gd3+ was added to the NMDG superperfusate, and any further reduction in the 
current density was analyzed (Figs. 2.2.B). Gd3+ did not significantly inhibit the leak current any 
further, indicating that Na+ is the major cation driving the Gd3+-sensitive inward current. Overall, 
these data suggest that the Gd3+-sensitive current in cultured hMSMCs is largely driven by Na+ 
conductance. 
2.3.2 NALCN Expression in the Human Myometrium 
Given that NALCN conducts a Na+-dependent, Gd3+-sensitive leak current and, like the 
myometrial leak current, can be modulated by G-protein coupled receptor (GPCR)-mediated 
signaling (17, 18, 24-26), NALCN was a prime candidate for the specific ion channel that 
conducts the myometrial leak current. To assess this possibility, NALCN expression was 
assessed in the human myometrium.  NALCN mRNA expression was detected in uterine tissue 
from pregnant term non-laboring (TNL) women by using non-quantitative RT-PCR (Fig. 2.3.A). 
Protein expression of NALCN was confirmed in TNL myometrial tissue by immunoblot (Fig. 
2.3.B). In hippocampal and ventral tegmental area neurons in the mouse and premotor 




Figure 2.3 mRNA and protein expression of NALCN in human myometrium.  
A) Representative RT-PCR of NALCN complex subunits (UNC79, UNC80, and NLF-1a) from human 
myometrial samples from four pregnant term non-labor (TNL) women.  Negative (no reverse 
transcriptase [RT]) and positive (human brain cDNA) controls are also shown.  B) Representative 
immunoblot of NALCN from TNL human myometrial sample membrane preparations from four different 
women. A mouse brain (msBr) membrane preparation served as a positive control. Transferrin receptor 





putative scaffolding proteins, UNC80 and UNC79, and a localization factor (NLF-1) (14, 17, 25, 
27) (Fig. 2.3.B). Non-quantitative RT-PCR showed that whereas UNC79 and NLF-1a were 
expressed in TNL human myometrial tissue, UNC80 was not (Fig. 2.3.A). However, UNC80 
expression was detected in uterine tissue from non-pregnant women (data not shown). 
 Many genes are regulated with the onset of labor, thus it was hypothesized that as an 
excitatory protein, NALCN expression would be upregulated with labor.  Quantitative RT-PCR 
of NALCN from human myometrium samples from preterm, not in labor (PTNL), preterm, in 
labor (PTL), term, not in labor (TNL), and term, in labor (TL) women revealed a range of 
variability, but no significant change in NALCN mRNA levels at any stage (Fig. 2.4).   
2.3.3 The Effect of NALCN Knockdown  
Importantly, Gd3+ has many ion channel targets (28, 29) and, to date, no specific blockers 
of NALCN exist. Thus, to assess the contribution of NALCN to the leak current in hMSMCs, 
shRNAs were used to knock down its expression. Cultured hMSMCs were transduced with 
lentiviral vectors expressing shRNAs that target all isoforms of NALCN. NALCN mRNA was 
decreased by 50%, and protein expression was reduced by 80%-90% (Figs. 2.5.A and B); the 
level of transcript knockdown matches that previously observed by Swayne et al. (2009). 
NALCN levels did not notably differ between cells treated with transduction additive, polybrene, 
alone and those transduced with shScr (Fig. 2.5.B). Cells in which NALCN expression was 
reduced with shRNAs had 37% lower average leak current conductance and 20% lower average 
leak current density at -60 mV than control cells (Fig. 2.5.C and Table II). However, knockdown 
by shNALCN did not reduce the current to the same extent as 10 µM Gd3+. Importantly, Gd3+ 
does not completely abolish the leak current, likely because Gd3+-insensitive channels contribute 





Figure 2.4 Normalized NALCN mRNA levels in the human myometrium. 
Analyzed by qRT-PCR.  Preterm, non-labor (PTNL), preterm, in labor (PTL), term, non-labor (TNL), and 
term, in labor (TL).   SDHA and TOP1 were used as the reference genes. 
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NALCN to the Gd3+-sensitive leak current alone can be calculated by subtracting the Gd3+-
insensitive current. Doing this revealed that NALCN knockdown reduced the Gd3+-sensitive 
current density at -60 mV by an average of 42% (Fig. 2.5.D). Taken together, these data are 
consistent with the notion that NALCN significantly contributes to the Na+-dependent, Gd3+-
sensitive leak current in cultured hMSMCs.   
2.4 Discussion 
Uterine contractions are regulated by the coordination of depolarizing and repolarizing 
currents mediated by ion channel activity. Here, we present the identification of a likely source 
of myometrial excitation – a cationic leak current.  This current was Gd3+-sensitive, Na+-
dependent, and present in both freshly isolated and cultured hMSMCs. This is the first 
demonstration that NALCN is expressed in the human myometrium and that its expression 
significantly contributes to the leak current. Notably, knockdown of NALCN expression 
significantly reduced the leak current at a physiologically relevant membrane potential of -60 
mV.   
We found that NALCN-targeting shRNAs were able to reduce the Gd3+-sensitive 
conductance by 42% in hMSMCs. This substantial reduction indicates a significant contribution 
by NALCN to the leak current. Nonetheless, NALCN knockdown did not abolish the leak 
current in hMSMCs.  Although it is possible that the remaining ~10 - 20% of NALCN channels 
were capable of carrying 58% of the cell’s leak current, it is more likely that the remaining Gd3+-
sensitive (and also Na+-dependent) current is driven by additional channels that contribute to the 
leak current in MSMCs. For example, several transient receptor potential channels, which are 
sensitive to inhibition by Gd3+, have been described to contribute to MSMC currents (30-33). 




Figure 2.5 The contribution of NALCN to the Gd3+-sensitive leak current in hMSMCs.  
A) qRT-PCR analysis of NALCN mRNA levels after transduction with shRNAs. Bars represent the mean 
values ± SEM.  Levels were normalized to SDHA and TOP1 and compared to scrambled shRNA (shScr) 
levels (n = 3). B) Quantification of NALCN protein expression from immunoblots of cultured hMSMCs 
treated with polybrene alone or transduced with lentiviruses expressing shScr or NALCN-targeting 
shRNA (shNALCN).  Bars represent the mean values ± SEM, normalized to shScr levels (n = 4). Inset 
shows a representative immunoblot.  GAPDH served as loading control. C) Current-voltage relationships 
obtained from cultured hMSMCs transduced with shRNAs before and after treatment with 10 µM Gd3+.  
Symbols represent mean values ± SEM (N = 9-11). D) Gd3+-sensitive current density analysis at -60 mV.  
Symbols represent individual cells.  Lines represent mean values ± SEM.  * P = 0.0401.
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whole-cell recordings with poor seal quality of less than 1 GΩ (34).  However, we assured 
membrane seals of ≥ 1 GΩ in our experiments and therefore conclude that the inhibition 
observed by treatment with Gd3+ and removal of Na+ from the bath solution is channel specific.   
The low level of NALCN activity observed in hMSMCs could also be due to the fact that 
the uterine tissue we used was biopsied from the lower uterine segment.  This segment of the 
uterus has been shown to be less contractile than the uterine fundus (35, 36) and may express 
fewer excitatory ion channels such as NALCN.  Furthermore, we did not detect mRNA 
expression in TNL myometrium of an important NALCN complex subunit, UNC80. This finding 
is consistent with an observation that HEK293 cells have NALCN leak activity in the absence of 
UNC80 co-expression (9).  Therefore, although GPCR-mediated modulation of NALCN activity 
requires UNC80 expression, baseline NALCN leak activity appears to function independent of 
canonical UNC80. Controversy exists in the field as to whether NALCN is a true leak channel or 
is an agonist-induced (through GPCRs) non-selective, voltage-insensitive channel.  Although our 
work indicates that NALCN functions as a leak channel in MSMCs, MSMCs may express low-
level constitutive GPCR activity that keeps NALCN active in these cells, as discussed by 
Swayne et al. (18).  Acetylcholine and substance P, two agonists that increase uterine 
contractility, have been shown to activate NALCN in neurons, pancreatic β cells, and interstitial 
cells of Cajal (18, 19, 24-26, 37-39). Thus, the involvement of NALCN in agonist-induced 
contractility is an important subject for future research.  
Establishing the source of a non-selective leak current in the human myometrium fills an 
important knowledge gap in the field of myometrial physiology. Clues to the existence of this 
current have been reported over the last several decades. Miyoshi et al. described a Na+-
dependent Gd3+-sensitive leak current in the rat myometrium in 2003, but the channel conducting 
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this current had not yet been identified.  In 1971, Anderson et al. described a transient Na+- and 
Ca2+-conducting current in the rat myometrium that they hypothesized to be due to a single 
channel (40). They found that a low concentration of extracellular Ca2+ enhanced the leak current 
and that the membrane potential was reduced by nearly 10 mV in a Na+-free solution. NALCN is 
a good candidate to generate this current as this channel is activated by low extracellular Ca2+ 
through its regulation by the Ca2+-sensing receptor (17) and drives Na+-dependent membrane 
depolarization (9).   Studies also suggest that uterotonins such as acetylcholine increase the rate 
of membrane depolarization and increase the frequency of action potentials in the myometrium 
(24, 26).  Given that NALCN can be activated by acetylcholine through muscarinic receptor 3 in 
pancreatic beta cells (18), NALCN may play roles not only in spontaneous MSMC activity, but 
also in agonist-induced myometrial excitability.   
Through its effect on resting membrane potential, NALCN has been linked to the 
regulation of rhythmic activity and overall membrane excitability in a variety of biological 
systems (9, 12-14, 19). The discovery of its activity in the myometrium could have implications 
for all stages of reproduction, including sperm transport, embryo implantation, embryonic 
gestation, and parturition. These processes require a range of activity, including complete 
quiescence, subtle directional peristalsis, and rhythmic, maximal force contractions of the uterus. 
Considering NALCN’s effect on excitability, it is reasonable to hypothesize that altering 
NALCN expression or activity could significantly alter the contractile state of the uterus. In fact, 
the resting membrane potential of the human uterus changes throughout gestation (23) and likely 
drives the unique contraction phenotype of each phase. Thus, an important next step will be to 
measure NALCN’s contribution to the resting membrane potential and overall uterine 
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3.1 Introduction 
 Uterine contractility is tightly regulated during pregnancy to ensure an appropriate length 
(>37 weeks) gestation and successful parturition.  Throughout pregnancy, the uterus remains 
quiescent producing only asynchronous, regional contractions that permit development of the 
growing fetus.  During parturition, uterine contractions increase in force, frequency, and 
synchrony to enable effective expulsion of the infant.  The force and frequency of these 
contractions is an important feature monitored during labor, as measured by Montevideo units in 
humans.  Excessive contractility or tachysystole, endangers both mother and fetus by increasing 
the risk for uterine rupture and insufficient placental perfusion.  Conversely, dystocia or failure 
to progress through labor are some of the principal indications for caesarean sections (1, 2), 
which increase the incidence of severe maternal morbidity and the likelihood of placental 
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abnormalities in future pregnancies (3-5).  As the caesarean section rate in the US (32%) (6) is 
nearly triple the recommended rate by the World Health Organization (10 – 15%) , it is 
imperative that we understand normal labor progress as a component of our effort to reduce the 
caesarean section rate.  As part of that effort, there is also a need to better understand the basic 
molecular mechanisms behind normal labor, and specifically those that regulate contraction force 
and frequency. 
 Uterine contractions are myogenic and arise due to the underlying electrical activity of 
the MSMC.  Although myogenic in nature, this electrical activity can be modulated by hormonal 
stimuli, and can occur, albeit with limited synchrony, at all stages of pregnancy (7-9).  The 
electrical activity of the myometrium occurs through recurrent depolarization of the membrane 
potential that manifests as bursts of high frequency spikes, and this activity closely couples with 
the contractile activity.  Over 50 years ago, Marshall demonstrated that the amplitude, frequency, 
and contraction duration correlates to the number of cells that are simultaneously active, their 
electrical burst frequency, and the duration of the bursts (10).  Both Ca2+ and Na+ have been 
reported to contribute to the initiation of excitatory activity, although the role of Ca2+ has been 
better defined.   Upon spontaneous or agonist-mediated depolarization of the plasma membrane, 
voltage-gated Ca2+ channels activate and mediate an influx of Ca2+.  The increase in intracellular 
Ca2+ results in Ca2+-calmodulin binding and activates myosin light chain kinases to 
phosphorylate myosin, initiating actomyosin cross-bridge cycling and subsequent cell 
shortening.  Bursts are terminated and muscle relaxation occurs when voltage-gated and Ca2+-
activated K+ channels become activated to repolarize the plasma membrane, and when Ca2+ is 
pumped out of the cell or into the intracellular stores via ATPase-mediated transport (11).  To 
date, the bursting activity of MSMCs has been primarily attributed to the function of these Ca2+ 
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and K+ channels.  However, focusing on these channels alone leaves us with an incomplete 
understanding of the mechanisms which fine tune spike density and burst frequency, and 
therefore overall uterine contraction patterns. 
 We previously identified the expression and activity of a novel Na+ leak channel in 
human MSMCs, called NALCN, that may contribute to fine tuning uterine excitability (12). 
NALCN is a tetrodotoxin-insensitive member of the 4x6 transmembrane domain family of 
voltage gated Ca2+ (Cav) and and Na+ (Nav) channels.  Because NALCN lacks some of the 
charged residues in the would-be voltage sensing domain, NALCN is voltage insensitive (13).  
Additionally, NALCN’s selectivity filter is a fusion of that found in Navs and Cavs, making 
NALCN a non-selective channel, allowing it to conduct Na+> K+> Cs+> Ca2+ with decreasing 
permeability (13).  Under physiological conditions, the driving force and greater Na+ 
permeability pushes NALCN toward conducting a constitutive Na+ leak current.  Through its 
Na+ leak activity, NALCN has been shown to be essential in depolarizing the membrane 
potential, promoting spontaneous firing, and sustaining rhythmic burst activity in other 
spontaneously active cells (13-16).  Previously, Na+ conductance in the myometrium had been 
hypothesized to play a limited role in MSMC excitability, as the presence and identity of 
tetrodotoxin (a blocker of fast Na+ currents) -sensitive currents have not been clearly established 
in MSMCs (17, 18).  However, historically Na+ has been implicated as an important ion in 
regulating myometrial excitability (19-21).  We hypothesized that the Na+ leak activity of 
NALCN plays a critical role in regulating myometrial excitability throughout pregnancy, and 
therefore is an important factor in pregnancy and parturition outcomes. 
 To gain a better understanding of the role of myometrial NALCN across pregnancy and 
in vivo, we transitioned to the mouse model. We created a smooth muscle specific knockout 
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mouse model of NALCN (smNALCN-/-) by crossing NALCN floxed mice with a myosin heavy 
chain 11 promoter driven Cre line (22).  With these mice, we tested the function of NALCN in 
the myometrium on gestational length, labor efficiency, and uterine excitability. 
3.2 Materials and Methods 
3.2.1 Mice 
All animal procedures complied with guidelines for the care and use of animals set forth 
by the National Institutes of Health. All protocols were approved by the Animal Studies 
Committee at Washington University in St. Louis. Wild type C57BL/6J mice were obtained from 
the Jackson Laboratory and bred in house.  NALCNfx/fx mice were a kind gift from Dr. Dejian 
Ren at the University of Pennsylvania.  These mice, bred on a C57BL/6J background, contain 
loxP sites surrounding the fourth and fifth exons of NALCN, which when excised results in an 
early termination codon before the fourth transmembrane domain of the first homologous repeat 
(15).  Female NALCNfx/fx mice were crossed with male myosin heavy chain 11 promoter driven 
Cre-eGFP mice (smMHCeGFP/Cre) (22).  The male NALCNfx/WT smMHCeGFP/Cre+/- F1 offspring 
were crossed NALCNfx/fx females to produce NALCNfx/fx smMHCeGFP/Cre+/- (smNALCN-/-), 
NALCNfx/WT smMHCeGFP/Cre+/- (smNALCN+/-), and NALCNfx/fx smMHCeGFP/Cre-/- (flox control) F2 
females that were used for parturition phenotyping.  This breeding scheme was chosen to avoid 
the creation of global NALCN knockouts, as smMHCeGFP/Cre females show aberrant Cre 
expression up to the early embryo stage.  Male smMHCeGFP/Cre gametes also express Cre during 
early spermatogenesis but it is lost before fertilization.  However, for this reason, the flox control 
and smNALCN-/- females are also globally heterozygous for NALCN.  Cre control mice used in 
parturition phenotyping were either F1 littermates, or were the offspring of smMHCeGFP/Cre males 
crossed with wild type females. 
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 K. Joseph Hurt generously gifted us with uterine tissue from pregnancy day 19.5 non-
labor and laboring, and post-partum C57BL/6 mice.  All protocols were approved by the 
University of Colorado Institutional Animal Care and Use Committee.  These mice were 
obtained from Charles River Laboratories. 
3.2.2 RNA Isolation and RT-PCR 
Total RNA was extracted from flash frozen whole mouse uterine or brain tissue using the 
Aurum Total RNA Fatty and Fibrous Tissue Pack Kit (BioRad, Hercules, CA), and copy DNA 
was created using the iScript cDNA Synthesis Kit (BioRad), both according to manufacturer’s 
instructions. PCR was performed to determine the presence of NALCN and other proteins with 
which it complexes, UNC79, UNC80, and NLF-1 in mouse uterine tissue at different stages of 
pregnancy.  PCR reactions included Taq PCR Master Mix (2X) (Affymetrix, Santa Clara, CA), 
gene specific primers (20 nM) (Table 3.1) (Integrated DNA Technologies, Coralville, IA), 0.5 µl 
DMSO and 2 µl cDNA per 25 µl reaction.  Reverse transcriptase-free reactions were also 
performed to confirm the absence of genomic DNA contamination (data not shown).  Reactions 
were run for one 5 min cycle at 95 °C, 40 cycles of one min at 95 °C / one min at 55 °C / one 
min at 72 °C, and one 5 min cycle at 72 °C. Results were electrophoresed on 1.5% agarose gels 
and visualized using GelRed Nucleic Acid Stain (Phenix Research Products, Candler, NC).   
3.2.3 Quantitative Real Time PCR (qRT-PCR) 
After dissection, mouse uterine tissue was immediately transferred into a vial of 
RNAlater® (Thermo Fisher Scientific, Waltham, MA) and stored at -20 °C until ready for RNA 
extraction.  RNA was extracted as detailed above, and quality was confirmed by 28S to 18S 
rRNA analysis via gel electrophoresis, and 260/280 nm and 260/230 nm absorbance ratios above 
1.8 and 2.0, respectively.  qRT-PCR reactions were performed in the same way as written in 
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chapter two.   qRT-PCR reactions (20 µl) contained 5 pmol of each forward and reverse primer 
(Table 3.1), cDNA produced from 50 ng of RNA, and iQ SYBR Green Supermix (BioRad). 
Gene targets were amplified and quantified by the CFX96 BioRad Real-Time PCR Detection 
System.  The temperature cycles were as follows:  95°C for 3 min (1X), and 95°C for 10s 
followed by 57°C for 30s (40X), ending with a 0.5°C increment melt curve from 65°C to 95°C.  
Primer efficiencies were ≥ 77% with mouse brain cDNA, and the calculated efficiency values 
were used in Pfaffl analysis of relative gene expression (23).  Target gene expression was 
normalized to the reference genes topoisomerase I (TOP1) and succinate dehydrogenase 







3.2.4 Membrane Preparations   
Flash frozen mouse uterine or brain tissue was minced over ice, and transferred to ice 
cold membrane prep solution (250 mM sucrose, 50 mM MOPS, 2 mM EDTA, 2 mM EGTA, 1 
mM PMSF, pH 7.4) containing cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail (Roche, 
Indianapolis, IN).  Tissue was homogenized using the BioGen PRO200 homogenizer 
(ProScientific, Oxford CT) at 4 °C.  Lysate was spun at 14,000 ×g for 15 min, and supernatants 
were transferred to ice cold ultracentrifuge tubes.  Samples were centrifuged at 100,000 ×g for 
one hour.  Pellets were resuspended in 1% Triton lysis buffer (150 mM NaCl, 10 mM Tris, 1% 
Triton X-100, pH 8.0), and rotated for two hours or overnight (no noticeable difference) at 4 °C.  
Non-solubilized protein was removed via centrifugation at 9000 ×g for 20 min at 4 °C.  
Membrane prep protein concentration was quantified via Bicinchoninic Acid Kit for Protein 
Determination (Thermo Scientific).   
3.2.5 Immunoblot 
Immunoblots were performed in a similar fashion as in chapter 2.  Protein samples were 
mixed with Laemmli sample buffer, heated to 65°C for 15 min, and stored at -20°C. Protein 
samples (40 µg for myometrium) were separated by 6% SDS-PAGE and transferred to a 
nitrocellulose membrane. After blocking in PBS containing 0.075% Tween-20 (PBST) and 5% 
milk, membranes were probed with the following primary antibodies: anti-NALCN N-20 (1:500; 
Santa Cruz Biotechnologies, Inc., Santa Cruz, CA, USA), anti-PDI (C81H6, Cell Signaling 
Technology, Danvers, MA), anti-GAPDH (1:1000; Millipore, Billerica, MA, USA), or anti-
transferrin receptor (1:1000; 84036 Abcam, Cambridge, UK). Blots were then probed with HRP-
conjugated secondary antibodies (1:4000; Jackson ImmunoResearch Laboratory Inc., West 
Grove, PA, USA) in PBST containing 3% milk.  Signal was detected with Clarity ECL Western 
chemiluminescence (BioRad) and exposed onto film or viewed through a ChemiDoc MP 
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Imaging System (BioRad).  NALCN expression was quantified and normalized to loading 
controls by using ImageJ densitometry.  
3.2.6 Current Clamp 
Mice were sacrificed between 9 and 11 am, their uteri were removed, and embryos were 
sacrificed.  The uterus was dissected to obtain 1 cm long by 0.5 cm wide strips of longitudinal 
muscle from all uterine regions, excluding the mesometrial border, in cold Kreb’s buffer (133 
mM NaCl, 4.7 mM KCl, 11.1 mM glucose, 1.2 mM MgSO4, 1.2 mM KH2PO4, 1.2 mM CaCl2, 
10 mM TES free acid, pH to 7.4 with NaOH).  Muscle strips were maintained in ice cold Kreb’s 
until experiments began (within six hours).  For recordings, strips were pinned into a recording 
chamber on a Nikon Eclipse FN1, and superfused with warm (32 °C) Kreb’s solution containing 
5 µM wortmannin, to mechanically inhibit contractions while maintaining spontaneous electrical 
activity.  Sharp glass electrodes with tip resistances between 40 mΩ and 110 mΩ were filled with 
2 M KCl and used to impale the tissue once contractions had arrested (usually within 15 
minutes).  Membrane potential was recorded at a 1 kHz sampling rate using an Axon Multiclamp 
700B amplifier and Axon Digidata 1550.  Data was recorded through the pCLAMP 10.4 
software.  Burst duration (time between first and last peak (spike)), burst interval (time between 
last peak of the previous burst and first peak of the next burst), peaks per burst, and peak width 
were analyzed using a customized Matlab program on Matlab R2015b.  In this program, we 
modified the ‘find peaks’ function to identify voltage peaks without the need to adjust for 
changes in baseline, or reduce noise.  Peaks were defined by having a minimum prominence of 7 
mV, and a minimum width of 20 ms.  Clusters of peaks, or bursts, were defined by a minimum 
duration of 2000 ms, and a minimum interval of 4000 ms.  For the across pregnancy data, 
representative ranges of four bursts and four intervals were selected from a representative 
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recording for each mouse, chosen by a technician blinded to the pregnancy stage.  For the 
transgenic mouse experiments, all available burst data was analyzed and included in the 
summative data. 
3.2.7 Parturition Phenotyping 
Cre control, flox control, smNALCN+/-, and smNALCN-/- female mice between the ages 
of seven weeks and six months were mated with WT C57BL/6J males ages eight weeks to eleven 
months, for two hours between 2:30 pm and 5:30 pm.  At the end of the two-hour period, 
females were checked for the presence of a copulation plug.  On days 17 or 18 of pregnancy, 
females were placed in individual cages in front of D-Link DCS-932L surveillance cameras 
(Taipei, Taiwan).  Cameras capturing one frame/second began recording at 7pm on day 18 of 
pregnancy (P18) and were stopped after delivery was completed, or when the female was 
sacrificed.  Dams were sacrificed due to painful delivery if they had not finished delivering by 
P22.  Videos were watched to determine the timing of delivery of each pup.  Gestation length 
was defined as the length of time between when the copulation plug was detected on day zero 
(about 5:30 pm) and when the first pup was delivered.  If a female did not deliver, then the 
gestational length was taken as the time when she was sacrificed (no later than P22).  Duration of 
labor was defined as the length of time between the delivery of the first and last pups, and 
adjusted labor duration was calculated by dividing the total labor duration by one less than the 
total number of pups delivered.  Prolonged labor was defined as the adjusted labor taking longer 
than two standard deviations from the Cre control and flox control mice (>27.5 min).  Labor was 
considered dysfunctional when a dam was unable to deliver her entire litter by P22.  Litter size 
included all fully grown pups or embryos, alive or dead at term or at pregnancy day 19 (P19), i.e. 
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early pregnancy fetal demises (in utero clots) were not counted.  Pup weights were taken within 
26 hours of birth. 
3.2.8 Staging Diestrus 
Mice in the diestrus stage of the estrus cycle were identified using previously described 
methods (25). Briefly, between 2:00 pm and 4:00 pm daily, DPBS vaginal lavages were 
performed and streaked out on glass slides.  Slides were stained with Crystal Violet (Sigma-
Aldrich, St. Louis, MO) and visualized on a Leica ICC50 upright microscope.  Lavages 
consisting primarily of leukocytes were considered to be from females in diestrus.  Females in 
diestrus were sacrificed between 3:30 and 5:00 pm and their uteri removed and flash frozen. 
3.2.9 MSMC Isolation 
Uterine longitudinal muscle was dissected from the same P19 flox control and 
smNALCN-/- mice used in the sharp electrode experiments.  The muscle was dissected in cold 
DPBS (Gibco, Grand Island, NY), and cut into ~3 mm x 8 mm strips.  About 10 – 15 strips were 
used per experiment.  MSMCs were isolated according to previously described methods (26).  
Tissue was incubated at room temperature in two ml of 0.1% BSA (Research Products 
International, Mt Prospect, IL) containing dissociation solution (145 mM NaCl, 4 mM KCl, 10 
mM HEPES, 10 mM glucose, 0.05 mM CaCl2, 1 mM MgCl2, pH to 7.4 with NaOH) for 10 min.  
It was then transferred to dissociation solution containing 0.1% BSA, 1.5 mg/ml papain 
(Worthington, Lakewood, NJ), and 1 mg/ml dithioerythritol (Sigma-Aldrich, St. Louis, MO) at 
37 °C for 15 min with occasional mixing.  It was then transferred to dissociation solution 
containing 1.5 mg/ml collagenase blend type H (Sigma, St. Louis, MO), 1 mg/ml soybean 
trypsin inhibitor (Worthington), and 0.5 mg/ml elastase (Worthington) for 5 min at 37 °C  and 2 
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min on ice.  Tissue was transferred to cold dissociation solution, dispersed by gentle pipetting, 
and transferred to 8 mm coverslips.  Cells were kept at 4 °C for 90 minutes before recording.  
3.2.10 Whole Cell Voltage Clamp 
Coverslips were transferred to a recording  chamber containing room temperature bath 
solution designed to isolate the leak current (125.4 mM NaCl or N-methyl-D-glucamine, 20 mM 
TEA-Cl, 0.1 mM MgCl2, 5 mM HEPES, 11 mM glucose, 1 µM CaCl2, and 5 µM nifedipine, pH 
7.4 (12, 27). TEA and nifedipine were included to inhibit the major contributing K+ and voltage-
gated Ca2+ currents in MSMCs.  Glass electrodes with resistances between 2 mΩ and 6 mΩ were 
filled with intracellular solution containing 125 mM Cs-Aspartate, 20 mM TEA-Cl, 5 mM Mg-
ATP, 5 mM EGTA, 100 nM free CaCl2, and 10 mM HEPES, pH 7.2.  Currents were measured in 
response to a voltage step protocol in which the holding potential of -55 mV was raised to +40 
mV for 100 ms (to inactivate voltage-gated Ca2+-channels), followed by 20 mV, 500 ms voltage 
steps from 100 mV to +40 mV.  Currents were normalized to the cell’s average capacitance.   
The current to voltage relationship was plotted, and the slope of the linear regression from -100 
mV to -20 mV was calculated.  Slopes that did not reduce by >25% by treatment with 10 µM 
Gd3+ were considered Gd3+-insensitive and excluded from final analysis.  Normalized 
conductance was determined by calculating the slope of the linear regression for currents elicited 
by voltages between -100 mV and -20 mV, as this was the most linear part of the currents.  
Reversal potentials were similarly determined by calculating the X-intercept of the linear 
regressions and calculating the mean ± SEM.   
3.2.11 Statistical Analysis 
Data comparing more than one group with one dependent variable was analyzed using 
Kruskal-Wallis one-way ANOVA. Individual differences were further assessed by Dunn’s 
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multiple comparisons test.  Experiments with only two groups were compared using Mann 
Whitney student’s t-test.  Statistics were done with GraphPad Prism 6 (San Diego, CA, USA) 
software.  Those with P values < 0.05 were considered significant.   
3.3 Results 
3.3.1 NALCN Expression in the Mouse Uterus 
Previously, we have shown that NALCN mRNA and protein are expressed in human 
myometrium, where it conducts a leak current (12) .  In order to better understand the function of 
NALCN in myometrial physiology and pregnancy outcomes, we elected to use a mouse model of 
pregnancy.  First, to determine whether NALCN is expressed in the mouse uterus, we performed 
non-quantitative, reverse-transcriptase PCR of NALCN and its complex components, UNC79, 
UNC80, and NLF-1a, from mouse uterine tissue across pregnancy (Fig 3.1.A).  All members of 
the NALCN complex were present in whole mouse uteri from every stage of pregnancy (non-
pregnant (NP), day 14 of pregnancy (P14), day 18 of pregnancy (P18), and day 19 of pregnancy 
(P19)), though the presence of UNC80 was variable in P19 samples.  Quantitative real-time PCR 
showed that NALCN mRNA levels were attenuated mid-pregnancy, however this did not reach 
significance (Fig 3.1.B).  However, western blot analysis of membrane preparations of mouse 
uteri taken from mice at different stages of pregnancy showed high levels of NALCN in NP and 
early pregnant mice (P7 and P10), and showed a decrease in late pregnancy (P14 and P18) (Fig 
3.1.C and D).  At term (P19) NALCN levels begin to increase again, and they increase further 
post-partum day 0.5 (PP0.5).  Western blot analysis of uterine tissue from a separate pool of P19 
mice that were either not in labor or in labor, or within one day post-partum (PP0.5), showed that 
NALCN levels increased during labor and were significantly different between non-labor and 




Figure 3.1 NALCN levels throughout pregnancy and post-partum. 
A) Reverse transcriptase PCR of NALCN and members of its complex (UNC80, UNC79, and NLF-1a) in 
the non-pregnant (NP), and pregnant day 10, 14, 18, and 19 mouse uterus.  Mouse brain cDNA and water 
are included as positive and negative controls, respectively.  B) Average of qRT-PCR analyses of 
NALCN mRNA in the mouse uterus across pregnancy.  TOP1 and SDHA were included as reference 
genes.  C) Representative western blot of NALCN protein levels across pregnancy in the mouse uterus.  
PDI is the loading control. D)  Quantification of NALCN protein levels in mouse uterine membrane 
preparations from across pregnancy.  NALCN levels were normalized to an internal standard.  One-way 
ANOVA P < 0.01, multiple comparisons show P14 and P18 are different from P7 (* P < 0.05).  E) 
Western blot of NALCN from mouse uterine membrane preparations of mice at term non-labor, term in 
labor, and post-partum day 0.5 (PP0.5).  F) Quantification of NALCN levels from western blot in (D).  
PP0.5 is significantly different from non-labor.  One-way ANOVA P < 0.01, multiple comparisons show 
non-labor significantly less than PP0.5 (* P < 0.05).  B, D, and F, n values are printed below the bars.
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contractile post-partum estrogen surge. 
3.3.2 Myometrial Excitability Throughout Pregnancy 
We next sought to investigate whether the changes in NALCN expression that were 
observed across pregnancy correspond with changes in uterine excitability.  To address this 
question, we performed sharp electrode current clamp experiments on mouse uterine longitudinal 
muscle to assess electrical activity across pregnancy.  These recordings demonstrate the pattern 
of spontaneous bursts over time (Fig 3.2.A).  From these recordings we analyzed the burst 
duration (time between first spike and last spike of a burst), burst interval (time between last 
spike of one burst and first spike of the next burst), the number of spikes per burst, and the spike 
density within each burst.  We hypothesized that during stages of pregnancy with higher 
NALCN expression we would see shorter inter-burst intervals (i.e. higher frequency bursting), 
and a greater spike density, which would enable more frequent and forceful contractions. P18 
myometrium showed a significantly prolonged average burst interval compared to P7 
myometrium (Table 3.3, Fig 3.2.B). Interestingly, the burst interval shortened again at term 
(P19), and was not significantly different from P7.  This correlates with high NALCN in the P7 
uterus, low levels at P18, and intermediate levels at P19.  Unlike burst interval, burst duration 
increased steadily throughout pregnancy (Table 3.3, Fig 3.2.C).  Bursts were significantly longer 
in duration in P14, P18, and P19 myometrium compared to P7.  Interestingly, this does not 
follow the same pattern as NALCN expression, however, there are many other ion channels 
important for burst duration which also change expression throughout pregnancy (28-33).   
Finally, we assessed the number of spikes per burst and normalized these to the burst duration to 




Figure 3.2 Myometrial excitability from across mouse pregnancy.   
A) Representative membrane potential traces from P7, P18, and P19.  B)  Average burst interval from 
across pregnancy. One-way ANOVA P < 0.01, multiple comparisons analysis shows P18 is significantly 
longer than P7, (** P < 0.01.  C) Average burst duration from across pregnancy. One-way ANOVA P < 
0.01, and multiple comparisons analysis shows P14, P18, and P19 are significantly longer than P7 (** P < 
0.01), and P19 is also significantly longer than P10 (# P < 0.05).  D) Average spikes per burst from 
throughout pregnancy. E) Average spike density from throughout pregnancy.  One-way ANOVA P < 
0.001, and multiple comparisons analysis shows P14, P18, and P19 are significantly shorter than P7 (** P 
< 0.01).  B – D, n values are printed on the bars.
 77 
 
density at P7 and lower densities at P14, P18, and P19.  Although we expected that if NALCN 
increases the frequency of spikes, then spike density would be highest in P7 and reduced in P14 
and P18 when NALCN levels are low, we also expected spike density to increase from P18 to 
P19.  These data suggest that changing NALCN levels may be important for uterine excitability.  
However, the concurrent regulation of other ion channels across pregnancy, and the lack of an 
NALCN specific blocker made it difficult to assess the role of NALCN in wild type uteri, and 
led us to pursue a uterine specific NALCN knockout mouse. 
3.3.3 NALCN Smooth Muscle Knockout Mouse (smNALCN-/-) 
To examine the role of NALCN in modulating myometrial burst activity and the effect 
that this may have on pregnancy outcomes, we created a smooth muscle specific, NALCN 
knockout mouse.  We crossed the myosin heavy chain-11 promoter driven Cre-IRES-eGFP 
mouse (smMHCeGFP/Cre) (upon recommendation by Francisco DeMayo) with an NALCNfx/fx 
mouse to create smNALCN-/- mice (Fig 2.3.A) (15, 22).  NALCN has not been reported in 
association with any vascular or severe gastrointestinal phenotypes, and we did not observe any 
significant non-reproductive phenotypes.  Through western blot analysis and fluorescent 
microscopy, we observed that the myometrial smooth muscle of smNALCN-/- mice expressed 
GFP, and therefore were also expressing Cre recombinase (Fig 3.3.B and D).  Western blot 
analysis of uterine membrane preparations from non-pregnant mice in the diestrus stage showed 
a reduction of NALCN expression in smNALCN-/- mice compared to flox controls, although it 
was incomplete and variable (Fig 3.3.D).  Incomplete knockout due to variable Cre expression 
across smooth muscle cells has been demonstrated before with this Cre line (34).  Another likely 
cause for the incomplete knockout of NALCN in the uterus is because there is remaining 




Figure 3.3 Development of the smNALCN-/- mouse.   
A) SmMHCeGFP/Cre males were crossed with NALCNfx/fx to produce smNALCN+/- offspring.  These males 
were crossed with NALCNfx/fx females to create the F2 females examined in this study, including flox 
controls (black box), smNALCN-/- (red box), and smNALCN+/- (pink box). B) Confirmation of GFP 
expression in the uterine longitudinal muscle of smNALCN-/- uterus.  C) Representative western blot of 




osmoregulation as NALCN has been reported to be  have been identified in the endometrium 
(35).  Additionally, the smNALCN-/- mice used in these experiments were sacrificed after their 
first or second parity, and had less severe parturition outcomes.  Thus, a greater reduction may be 
observed when the total population, including those mice that have more severe phenotypes, is 
represented.  These data demonstrate the knockout of NALCN specifically in the myometrium, 
but indicate some degree of variability in the level of NALCN knockout from mouse to mouse.  
3.3.4 Parturition Phenotype in smNALCN-/- Mouse 
We tested the role of myometrial NALCN expression on pregnancy outcomes by 
comparing the labor parameters of smNALCN-/-, smNALCN+/-, Cre control, and flox control 
females.  All genotypes were mated with WT males for two hours and then were checked for the 
presence of a copulation plug.  Beginning on P18, females were observed via surveillance 
camera for their time and length of delivery.  The length of time from copulation to the time of 
delivery of the first pup (gestation length) was not significantly different between the four 
genotypes, nor was the duration in labor (Table 3.2, Fig 3.4.A).  However, smNALCN-/- dams 
showed a reduced litter size, averaging 4.9 pups/litter compared to 7.1 pups per litter for flox 
control littermates (Table 3.2, Fig 3.4.B).  Although the mean gestation length did not 
significantly differ between groups, we observed that the number of pups per litter correlated 
with the gestation length in smNALCN-/- females, in that smaller litters delivered later (Fig 
3.5.A).  Likely because of the slightly longer gestation length, and greater maternal resource per 
pup, pups from smNALCN-/- and Cre control pregnancies were also larger (Fig 3.5.B).  These 
data support the notion that there is a fetal component in determining gestation length (36, 37).  




Figure 3.4 Pregnancy parameters in smNALCN-/- mice. 
A)  Average time to delivery of the first pup. One of the smNALCN-/- females did not deliver; the time 
that she was sacrificed is included instead.  B)  Average litter size.  These data include mice that were 
observed via surveillance cameras, as well as the litter sizes of P19 mice sacrificed for electrophysiology 
experiments. One-way ANOVA P = 0.05, multiple comparisons analysis show smNALCN-/- are 
significanty smaller than flox controls (* P < 0.05). C)  Labor duration adjusted for litter size.  Mice with 
dysfunctional labor were excluded from this analysis.  One-way ANOVA P = 0.05, multiple comparisons 
analysis show smNALCN-/- are significanty longer than flox controls (* P < 0.05). D)  Rate of prolonged 





Figure 3.5 (Supplemental) The effect of litter size on gestation length and pup weight. 
A) Correlation analysis of litter size and the time to delivery of the first pup, or time of sacrifice (in the 
case of one smNALCN-/- that was unable to deliver any pups). SmNALCN-/- mice showed a slope that 
was significantly non-zero, linear regression analysis P < 0.05.  B) Average pup weights (recorded < 26 
hour after birth) by dams of indicated genotypes.  Pups weighed are from an 3, 6, 3, and 5 litters, 
respectively.  n value of individual pups is printed on the bars.  One-way ANOVA P < 0.01, and multiple 
comparisons anlysis shows that pups of Cre control and smNALCN-/- dams are significantly larger than 








rate of dysfunctional labor (those that were unable to deliver their full litter by P22).  33% of 
smNALCN-/- dams had dysfunctional labor compared to 9% of flox controls, and 0% of Cre 
controls and smNALCN+/- dams (Fig 3.4.D).  When accounting for the reduced litter size of 
smNALCN-/- females, we also found that they had an extended time in labor compared to flox 
controls, taking about 30 min to deliver each pup, compared to the 15 min of flox controls (Table 
3.2, Fig 3.4.C).  Considering prolonged labor as an adjusted labor duration more than two 
standard deviations outside of Cre and flox controls (>28 min), we found that smNALCN-/- dams 
experienced an increased rate of prolonged labor (44% compared to 0% flox controls, 17 % Cre 
controls, and 29% smNALCN+/- dams) (Table 3.2, Fig 3.4.D).  On the whole, smNALCN-/- 
showed a significant reduction in the rate of normal labor (Table 3.2, Fig 3.4.D).  The variability 
of the smNALCN-/- phenotype is likely associated with the observed variability in NALCN 
knockdown (Fig 3.3.D).  In summary, these data demonstrate the necessity of myometrial 
NALCN expression in efficient and successful labor outcomes. 
3.3.5 Uterine Excitability in smNALCN-/- Mouse 
 To determine whether the increase in dysfunctional labor in smNALCN-/- mice is related 
to uterine excitability we again used sharp electrode current clamp to compare P19 smNALCN-/- 
dams and P19 flox control dams (Fig 3.6.A).  We found that myometrium from smNALCN-/- 
dams showed no significant change in burst interval or spike density (Table 3.3, Fig 3.6.B and 
E).  However, average burst duration and the number of spikes per burst were significantly 
reduced in smNALCN-/- dams (Table 3.3, Fig 3.6.C and D).   This indicates that NALCN is 
important in sustaining burst duration at P19.  Unexpectedly, whole cell patch clamp showed no 
difference between the Gd3+- sensitive leak current in MSMCs from flox control and  
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Figure 3.6 Myometrial excitability in smNALCN-/- uterus.   
A) Representative membrane potential traces from P19 flox control and smNALCN-/- longitudinal muscle.  
B – E) Average burst interval, burst duration, number of spikes per burst, and spike density in flox control 
and smNALCN-/- longitudinal myometrium. Burst duration is decreased in smNALCN-/- (t-test, * P < 
0.05), and the number of spikes per burst is significantly reduced in smNALCN-/- compared to flox 
control (t-test, ** P < 0.01). F) Average leak current density vs. voltage in smNALCN-/- and flox control 
mMSMCs.  G) Gd3+-sensitive current density evoked at -60 mV in flox control and smNALCN-/- 
mMSMCs. B – E, and G, n values are printed on the bars.
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Table 3.3  




smNALCN-/- mice (Fig 3.6.F and G).  In summary, at P19 NALCN regulates myometrial 
excitability and does so by sustaining the burst duration. 
3.4 Discussion 
 We previously identified the expression and activity of the Na+-leak channel, NALCN, in 
human MSMCs (12).   Here, we have gone on to show that NALCN is important in uterine 
physiology.  We found that NALCN is expressed and regulated across pregnancy in the mouse 
uterus, and its expression is critical for facilitating labor.  Specifically, smNALCN-/- females 
showed an increased incidence of prolonged or dysfunctional labor, and reduced uterine 
excitability compared to flox control mice.  Our study is novel in that it establishes the role of a 
Na+ channel in regulating labor efficacy, and expands our understanding of the electrical 
mechanisms involved in parturition.   
 Our study supports the findings of others that Na+ does in fact play an important role in 
uterine excitability (19-21).  Researchers have reported that the regenerative bursting properties 
of estrogen-treated, non-pregnant rat, and the pregnant rabbit myometrium relied on the presence 
of Na+ (19, 20, 21,38).  And others have reported the presence of a Na+-dependent leak current in 
rat MSMCs (27).  Our study identified a specific Na+ channel in the mouse myometrium, and its 
necessity in uterine excitability and parturition outcomes.  In addition to finding a novel mediator 
of uterine excitability, this study emphasizes that even subtle changes in ion currents in the 
myometrium can have a large impact on reproductive success.   
  Our studies indicate that burst interval correlates with NALCN expression, which was 
expected based on the established ability of NALCN to increase spontaneous firing (13-15). 
However, our recordings in smNALCN-/- P19 myometrium did not show a prolonged burst 
interval, but rather showed a burst duration and number of spikes per burst compared to flox 
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controls, with no change in spike density.  Despite our initial hypothesis that NALCN would 
contribute mainly to burst interval, our finding that it contributes to burst duration is also 
unsurprising as NALCN has now been shown to contribute to sustaining depolarization and 
spike trains in murine interstitial cells of Cajal and hermaphrodite specific neurons in C. elegans 
(16, 39).  Even so, NALCN levels are still rather low at P19, and thus a greater role for NALCN 
in regulating burst interval may be observed in stages with increased NALCN expression, i.e. in 
labor, or at P7 and P10.  Also, because many ion channels are differentially regulated throughout 
pregnancy, the activity of NALCN, even if constant, may have a different effect on myometrial 
excitability because of its interaction with other channels.  This is likely why we observed a 
pattern of burst duration that differed from NALCN levels in our wild type burst analysis.   
 The reduced rate of normal labor, and a decrease in the number of spikes per burst in in 
the myometrium of smNALCN-/- females suggests that they have insufficient uterine activity to 
efficiently deliver their pups.  Four mice (three smNALCN-/- and one flox control) in our study 
experienced dysfunctional labor, and were typically able to deliver at least one pup around the 
normal time, and then were unable to deliver the remaining pups.  This suggests that other 
processes needed for labor to occur, including cervical ripening were proceeding, however the 
mice lacked the uterine activity to have a normal delivery.  SmNALCN-/- mice also showed a 
reduced litter size, which resulted in a slightly delayed onset to delivery, and larger pup sizes.  
The reason for the reduced litter size is unknown, but we expect that fetal loss occurs later in 
pregnancy, as we observed in a small subset of P10 mice (3 of each genotype), that smNALCN-/- 
had similar litter sizes as flox controls (data not shown).  We also noted a larger average pup 
weight in the smNALCN-/-.  The slightly longer time in utero, and reduced litter size likely 
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contributes the increase in pup size, and may contribute to the difficulty the smNALCN-/- dams 
experienced in labor.  
 In our study, we focused on the expression and role of only one member of the NALCN 
complex.  We found that NALCN is not only expressed in the mouse myometrium, but that its 
protein levels are regulated throughout pregnancy.  The pattern of NALCN expression suggests 
that NALCN may be negatively regulated by progesterone.  Progesterone levels peak in mid to 
late gestation (40) when NALCN levels are low, and then decrease for labor, when NALCN 
levels begin to increase.  Beyond reproductive tissues, this may have broad implications in the 
regulation of NALCN levels in the other tissues in which its expressed, particularly the pancreas 
and nervous system.  Interestingly, we observed that unlike the human, UNC80, an important 
scaffolding protein for NALCN, was expressed in the non-laboring uterus.  It will be important 
to parse out the regulation of NALCN complex proteins, including UNC80, UNC79, and NLF-1 
in the myometrium as these play an fundamental role in regulating NALCN levels and activity 
(41-44).   
It was also surprising to see high levels of NALCN in early pregnancy.  Although we do 
not currently understand the purpose for this, there are a few interesting possibilities.  In early 
pregnancy, when MSMCs are electrically uncoupled and the uterus is less contractile, MSMCs 
concurrently undergo rapid hyperplasia (45).  Depolarizing currents have been shown to 
contribute to cell proliferation, and therefore it is possible that NALCN may be important in 
early cell proliferation (46).  We did not observe an obvious defect in uterine hyperplasia in 
smNALCN-/- mice, however there may have been compensatory mechanisms to sustain 
proliferation, and we did not do intensive histology to determine whether there were architectural 
differences.  Another interesting role for NALCN would be in the endometrium.  Regulation of 
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uterine luminal fluid levels by ion channels ENaC and CFTR, have been suggested to play a role 
in embryo implantation (35).  NALCN has also been linked to osmoregulation (47), and 
therefore could contribute to this or other unknown processes in the endometrium. 
In summary, our study established a novel role for NALCN in regulating myometrial 
excitability and labor efficiency.  Future work should confirm the functional role of NALCN in 
the human myometrium, in order to validate NALCN as a potential target in the treatment of 
dysfunctional labor. 
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4.1 Introduction 
 The unique structure and function of specific tissues is established by the distinct 
regulation of their individual cells.   Cells modulate the transcription, translation, post-
translational modification, trafficking, and stability of specific gene products in a tissue-specific 
way.  Beyond the establishment of a tissue’s structure and function in early development, many 
tissues alter their functions to adapt to unique physiological or environmental challenges.  The 
myometrium is a striking example of a tissue that changes dramatically over a relatively short 
period of time in order to accommodate pregnancy.  These changes include: hypertrophy and 
hyperplasia (1), decreasing innervation (2-5), enhanced electrical excitability and connectivity 
(6-8), and increased mechanical stretch (9, 10).  The uterus also undergoes greater regional 
differentiation including the development of the embryo implantation site, as well as increased 
contractility at term in the upper segment compared to the lower segment.  Focusing our work on 
one gene in the mouse uterus, NALCN, we have demonstrated that it too shows dynamic 
regulation of its protein levels throughout pregnancy (Fig 3.1.C and D), and that this regulation is 
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likely important in the modulation of uterine excitability necessary for successful parturition.  
However, mechanisms by which NALCN protein levels are modulated in the myometrium are 
unknown.   
Proper uterine function during pregnancy relies on differential gene expression across 
different regions of the uterus (11). Beyond the endometrial and muscular layers, the mouse 
uterus can be superficially subdivided into broad regions 1) longitudinally into the cervical, mid, 
and ovarian sections, and 2) transversely into the mesometrial border (placental side) and anti-
mesometrial section (Fig 4.1).  It has been suggested that the ovarian end, much like the upper 
segment (fundus) of the human uterus, is the site of contraction initiation while the cervical end 
and lower segment are the sites with greater relaxation to allow expulsion of the fetus (12).   
Differences in gene expression have been observed across these regions (11, 13, 14).  Agonist 
sensitivity, especially carbachol-responsiveness was also demonstrated to be more dominant in 
the ovarian end than in the cervical end, likely due to differing levels of muscarinic receptor 3 
(15).  However, observations of electrical activity in the guinea pig uterus have shown that 
neither the ovarian nor cervical end are dominant in burst initiation (16).  Additionally, reports 
differ in their findings of the levels of excitability in the mesometrial border, the site of 
placentation in the mouse uterus, and the anti-mesometrial border.  Several reports have shown 
less electrical activity in the mesometrial border (17, 18) compared to the anti-mesometrial side.  
However, recently, Lammers et al. demonstrated a greater prevalence of bursting initiation and 
contraction origination at the mesometrial border in the rat and guinea pig uteri (19).  Based on 
these observations of regional differences in electrical activity, we hypothesized that NALCN 




Figure 4.1 Schematic of the gravid mouse uterus.  
The uterus can be subdivided longitudinally into ovarian and cervical sections, and transversely into the 
mesometrial border and anti-mesometrial section.  The mesometrial border includes the implantation sites 
where the placenta and maternal vasculature interact.  
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Beyond regional localization differences, proteins may also be individually modified to 
contribute to functional differences in the tissue.  We observed that NALCN mRNA and protein 
levels changed across pregnancy in the mouse uterus (chapter 3), but the assessment of mRNA 
levels and even total protein levels often fail to capture differences in intracellular localization, 
and post-translational modifications that can affect protein function.  One example in the case of 
NALCN, is its dependence on the accessory protein, NLF-1, for its localization to the cell 
membrane.  Alterations in NLF-1 expression can directly affect NALCN protein levels at the 
plasma membrane (20, 21).  Alternatively, ion channel function may also be regulated by post-
translational modifications, such as glycosylation.  Glycosylation, which occurs in the ER and 
Golgi apparatus, is an important post-translational modification that mediates proper protein 
folding, and trafficking to the cell membrane. The specific sequence of carbohydrate chains 
adjoined to glycosylated ion channels can have a direct effect on channel function (22).  For 
example, preventing the glycosylation of the voltage-gated K+ channel, Kv1.1, results in slower 
activation kinetics (23).  Interestingly, the pregnancy hormone progesterone has been associated 
with increased glycosylation of IgG1 antibodies (24), and therefore may have an unexplored 
function in regulating protein glycosylation in MSMCs.  We have not observed dramatic changes 
in NALCN mRNA across pregnancy in the mouse (Figure 3.1.B) or human (Figure 2.4) uterus, 
therefore we hypothesized that changes in NALCN protein levels may be mediated through post-
translational mechanisms, which regulate protein stability.  
Hormones, particularly progesterone and estrogen, are the major orchestrators of change 
in reproductive tissues like the uterus, and therefore are often the first candidates associated with 
pregnancy-mediated expression changes.  As previously mentioned, these hormones bind to their 
intracellular receptors (PR and ER) and enact changes in gene transcription by translocating to 
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the nucleus and binding to response elements in the promoter regions of an array of target genes 
to drive transcriptional activity (25).  They can also modulate the expression of genes lacking 
response elements by interacting with other transcription factors such as Sp1 and members of the 
AP-1 family (26, 27).  Progesterone and estrogen are thought to work in opposition, promoting 
the expression of target genes with opposing functions, or inhibiting expression of the other’s 
target genes (28).  Progesterone levels increase during pregnancy and are essential for 
maintaining pregnancy (29).  In the mouse, progesterone levels drop at term as a result of 
luteolysis, and this decrease precipitates labor.  Interestingly, uterine NALCN levels inversely 
correlate with serum progesterone levels.  We showed that uterine NALCN protein levels were 
high in early pregnancy, reduced in mid to late pregnancy, and then increased during labor and 
into the post-partum period (Figure 3.1.D and F).  In the mouse, the serum progesterone 
concentration reaches its peak during mid to late gestation, when NALCN protein levels are at 
their lowest (30).  Based on these data, we hypothesized that NALCN protein levels may be 
negatively regulated by progesterone.  
4.2 Materials and Methods 
4.2.1 Animal Studies 
All animal procedures complied with guidelines for the care and use of animals set forth 
by the National Institutes of Health.  All protocols were approved by the Animal Studies 
Committee at Washington University in St. Louis and the University of Colorado Institutional 
Animal Care and Use Committee.  C57BL/6 mice were obtained from Jackson Laboratories 
(those used in estrus cycle experiments) or from Charles River Laboratories (those used in 
progesterone and RU486 experiments). 
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4.2.2 Staging the Estrus Cycle 
The estrus cycle of non-pregnant mice was tracked by using previously described 
methods (31) summarized in chapter 3.  Mice were tracked for a minimum of one complete 
estrus cycle before they were sacrificed.  Four were sacrificed at each stage of the estrus cycle 
(proestrus, estrus, metestrus, and diestrus) between 2:00 and 5:00 pm. Their uteri were removed 
and flash frozen, and eventually their plasma membranes were isolated. 
4.2.3 Progesterone and RU486 Treatment 
Samples were a kind gift from K. Joseph Hurt, MD, PhD.  Briefly, one group of mice was 
treated in the evening with the progesterone receptor antagonist, RU486 (0.5 mg diluted in 150 
µL EtOH), or vehicle (150 µL EtOH) at P14.5 via subcutaneous injection.  Mice (controls and 
RU486 treated) were sacrificed at the time of delivery of the first pup in the RU486 group (< 24 
hours after treatment), their uterus was removed, cleared of its contents, and flash frozen in 
liquid nitrogen.  Females that did not go into preterm labor (~20%) were excluded.  A second 
group of mice was treated with progesterone (1 mg in 150 µL sesame oil) or vehicle (150 µL 
sesame oil) at P17.5 and a second dose was administered at P18.5.  Vehicle and progesterone 
treated mice were sacrificed after the delivery of the first pups of the vehicle treated mice 
(progesterone treated mice do not deliver).  The uteri from these mice were removed, the 
embryonic contents were cleared, and the uterus was flash frozen. 
4.2.4 Membrane Preparations 
Uterine tissue was minced and homogenized for isolation of their cell membranes.  The 





Immunoblots were run in the same way as described in the methods section of chapter 3.  
Pretreatment with the antigenic peptide is described in chapter 2. 
4.2.6 Glycosidase Treatment 
 Endoglycosidase H (endo H) and Peptide-N-glycosidase F (PNGase F) deglycosylation of 
mouse uterine membrane preps were performed using the associated kits from New England 
BioLabs.  Mouse uterine membrane preparations (30 µg in 15 µl) were denatured using the 10X 
Denaturing Buffer for 10 min at 100 °C.  For endo H reactions, 3 µl of 10X GlycoBuffer #3, 4.5 
µl water, and 7.5 µl (~3750 units) of endo H were added (30 µl total volume).  For PNGase F 
reactions, 3 µl of 10X GlycoBuffer #2, 3 ul 10% NP40, 6 µl water, and 3 µl PNGase F (~1500 
units) were added (30 µl total volume).  Reactions were incubated for one hour at 37 °C, then 
stopped with 10 µl of 4X Laemmli loading buffer and stored at -20 °C until SDS-PAGE. 
4.2.7 HEK293 Transduction with NALCN 
Lentiviral vectors were produced by the Washington University in St. Louis Hope Center 
Viral Vectors core using a pWPXL plasmid containing an HA tag-NALCN-IRES-NeoR cassette 
(a generous gift from Arnaud Monteil at the Institut de Génomique Fonctionnelle, Universités 
Montpellier).  HEK293 cells were suspended via 0.25% Trypsin-EDTA (Gibco), and washed 
twice with DMEM-Ham’s F-12 with 10% FBS and 25 µg/ml gentamicin (standard media).  
HEK293 cells were transferred to a conical tube containing 2 ml of standard media supplemented 
with 16 µg/ml polybrene and viral vectors, consisting of a multiplicity of infection of two.  The 
suspension was mixed briefly and then transferred to a cell culture-treated flask containing 2 ml 
of standard media.  Media was changed 16 hours later, and transduced cells were selected for 




4.3.1 Regional Localization of NALCN Isoforms 
In contemplating NALCN regulation, we first asked whether NALCN levels may differ 
according to the specific region within the uterus thus contributing to reported regional 
differences of excitability in the uterus.  NALCN levels in the ovarian end of the uterus were 
compared to the cervical end, as well as from the mesometrial border compared to the anti-
mesometrial border.  Western blot analysis on membrane preparations from these regions at NP 
and P18 showed no evidence for a difference in NALCN levels between the cervical and ovarian 
regions (Fig 4.1.A).  However, in comparing the mesometrial border and anti-mesometrial 
section, we observed an increased prevalence of a novel ~180 kDa band in P14 and P18. In the 
P19 uteri we detected a combination of the standard ~160 kDa band and the ~180 kDa band in 
the mesometrial border and anti-mesometrial sections (Fig 4.2.B).  To confirm the specificity of 
the NALCN antibody, I performed a western blot on lysates of HEK293 cells that had been 
transduced with a lentiviral vector to overexpress NALCN.  Figure 4.2.C shows increased 
intensity of the ~160 kDa band in the NALCN overexpressing cells compared to the vehicle 
treated cells, with no change in the loading control (GAPDH).  As an additional control, I 
performed a western blot on the P18 and P19 mesometrial border samples in which I pre-
incubated the primary antibody with the antigenic peptide, or used the secondary antibody alone.  
I did not observe any non-specific bands that remained in either of these control conditions (Fig 
4.2.D), indicating NALCN-specificity of the antibody.  The induction of a putative higher 
molecular weight isoform of NALCN in the mesometrial border lead us to hypothesize that 




Figure 4.2 Regional localization of NALCN.   
A) Western blot of mouse uterine membrane preparations from the ovarian (ov) and cervical (cerv) 
sections of the non-pregnant (NP) and pregnancy day 18 (P18) uteri.   TR is the loading control.  B) 
Western blot of mouse uterine membrane preparations from the mesometrial border (M) and anti-
mesometrial section (AM) of the P14, P18, and P19 uterus.  TR is the loading control.  C) Western blot of 
HEK293 cells transduced with a lentivirus overexpressing NALCN.  GAPDH is the loading control. D) 
Western blots of the P18 mesometrial border (P18, M), P19 mesometrial border (P19, M), and P19 anti-
mesometrial border (P19, AM).  The first blot is under standard conditions.  In the second blot, the 




4.3.2 N-Linked Glycosylation of NALCN  
As mentioned, the mesometrial border has been found to be a less excitable region of the 
uterus (17, 18).  Therefore, we hypothesized that there may be a mechanism to sequester an 
excitatory ion channel like NALCN to the endoplasmic reticulum in this region.  Many 
transmembrane proteins that are trafficked to the plasma membrane are glycosylated within the 
ER and Golgi apparatus, and the type of glycosylation can denote a protein’s intracellular 
location.  We hypothesized that the higher molecular weight band observed in NALCN western 
blots of the mesometrial border is a glycosylated form of the channel that may be sequestered to 
the endoplasmic reticulum.  First we asked whether NALCN contained putative asparagine (N)-
linked glycosylation sites.  These consist of an asparagine followed by any amino acid (except 
proline), and a serine or threonine (N-X-S/T).  We found six putative glycosylation sites.  Two of 
the sites are located on the cytoplasmic face of the protein, and although cytoplasmic proteins 
can be glycosylated, this form of glycosylation is less common (32).  The other four sites are 
located in the extracellular portion of the S5-S6 linkers in repeats I, III, and IV, outside of the 
pore regions, and are more likely candidates (Fig 4.3.A).  
 To determine the glycosylation status of NALCN, we employed the glycosidases, 
PNGase F and endo H.  These enzymes are commonly used to determine whether a protein has 
undergone N-linked glycosylation and whether it localizes to the ER, respectively (33).  We 
incubated mesometrial border membrane preparations from P18 and P19 mice with both PNGase 
F and endo H.   Neither PNGase F nor endo H caused any shift of the ~160 kDa band, indicating 
that this band is not N-glycosylated or sequestered to the ER (Fig 4.3.B and C).  However, the 
~180 kDa band was reduced to nearly 140 kDa by PNGase F treatment (Fig 4.3.B).  This 




Figure 4.3 NALCN N-linked Glycosylation.   
A) Schematic of NALCN with putative glycosylation sites denoted with green circles.  B) Pregnancy day 
18 (P18) and P19 mesometrial border (M) treated with and without PNGase F.  TR is a positive control.  




cause a significant shift in the molecular weight of the ~180 kDa band, indicating that NALCN is 
not sequestered to the ER (Fig 4.3.C).  Interestingly, the PNGase F-induced shift reduced the 
protein to a size that is even smaller than the non-glycosylated ~160 kDa form.  This indicates 
that two core forms of NALCN may exist, one that is ~160 kDa, and one that is ~140 kDa, with 
only the ~140 kDa protein showing end stage glycosylation. These experiments indicate that at 
the mesometrial border, there is a greater prevalence of a glycosylated, smaller core NALCN 
protein.  Further work needs to be done to determine the identity of the 140 kDa protein. 
4.3.3 NALCN Levels During the Estrus Cycle 
Based on our findings that NALCN levels are regulated throughout pregnancy, we 
hypothesized that NALCN may be negatively regulated by progesterone, and that progesterone 
may play a role in the regional differences observed in NALCN glycosylation.  First, to test the 
hypothesis that NALCN is regulated by progesterone, NALCN protein levels in the mouse uterus 
were assayed from tissue collected throughout the hormonally driven estrus cycle (Fig 4.4.A).  
The estrus cycle is broken down into four stages, diestrus, proestrus, estrus, and metestrus.  
During late diestrus and proestrus ovarian follicles are formed, and circulating estrogen levels 
increase to signal the release of follicle stimulating hormone and luteinizing hormone from the 
pituitary gland.  These hormones stimulate ovulation and the transition to the estrus stage, when 
the female becomes sexually receptive. Following estrus is metestrus, in which the corpus 
luteum is formed in preparation for pregnancy, and progesterone levels increase.  In the absence 
of pregnancy, the mouse reenters the diestrus phase (34).  We hypothesized that NALCN levels 
would peak during proestrus, when progesterone levels are at their lowest, and the estrogen to 
progesterone ratio is at its highest.  Estrus stages of mice were assessed via vaginal cytological 





Figure 4.4 NALCN levels in the mouse uterus across the estrus cycle.   
A) Schematic of the relative circulating progesterone and estradiol levels throughout the mouse estrus 
cycle. B) Representative western blot of NALCN from membrane preparations of mouse uterus collected 
from different stages of the estrus cycle.  PDI is the loading control.  C) Quantification of NALCN levels 
from across the estrus cycle. n is four for all stages.  One-way ANOVA P < 0.01, and multiple 
comparisons show that metestrus and estrus are significantly less than proestrus (* P < 0.05).
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processing.  Importantly, uteri were collected at a similar time each day, as the estrus cycle is 
also affected by circadian rhythms (35, 36). Western blot analysis was performed on membrane 
preparations, tagging for NALCN and protein disulfide isomerase (PDI) as the loading control 
(37).  As predicted, NALCN levels peaked in proestrus and were at their lowest in metestrus 
(Figure 4.4.B and C).  Interestingly, NALCN levels were also elevated during diestrus, when 
progesterone remains high.  However, despite high progesterone levels, during diestrus the 
estrogen to progesterone ratio begins to increase (Figure 4.4.A).  This suggests that beyond the 
serum progesterone levels, the overall estrogen to progesterone ratio may play an important role 
in regulating NALCN levels.  Taken together, the assessment of NALCN protein levels in the 
uterus across pregnancy and the estrus cycle demonstrate that NALCN levels are dynamically 
regulated in the uterus to accommodate the unique stages of the reproductive cycle, and that 
NALCN levels are dependent on circulating estrogen and progesterone levels. 
4.3.4 NALCN Levels in Response to Progesterone and RU486 Treatments 
To more directly ascertain whether NALCN is downregulated by progesterone, we 
assayed NALCN levels in the uteri of mice that had been injected with exogenous progesterone 
at term.  We obtained uterine tissue from our collaborator Dr. K. Joseph Hurt at the University of 
Colorado.  Mice were subcutaneously injected with 1 mg of progesterone or vehicle on days 17.5 
and 18.5 of pregnancy.  Vehicle and progesterone treated mice were sacrificed at the time of 
delivery of the first pups in the vehicle treated group, and uteri were collected.  The progesterone 
treated mice, because they do not experience progesterone withdrawal, do not go into labor. 
Western blot analysis of uterine membrane preparations revealed that delaying the progesterone 
withdrawal in mice, prevented the term increase in NALCN levels.  Uterine tissue from 
progesterone-injected mice had an 86% reduction in NALCN (~160 kDa band) compared to 
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vehicle-injected mice (Fig. 4.4.A and B).  Surprisingly, we again saw the appearance of the 
higher molecular weight (~180 kDa) band in some of the progesterone treated tissues (6 of 10 
progesterone treated samples compared to 1 of 8 control samples).  
To further examine NALCN regulation by progesterone, we also performed the reverse 
experiment by blocking progesterone receptors with the antagonist, RU486, at P14.5 when 
progesterone levels are naturally high.  Mice were subcutaneously injected with 0.5 mg of 
RU486 or vehicle in the evening of P14.5.  They were sacrificed at the time of delivery of the 
first pup of the RU486 treated mice, < 24 hours later (vehicle mice do not deliver during this 
time).  We hypothesized that blocking progesterone signaling during mid-gestation would relieve 
the inhibition on NALCN expression and uterine NALCN levels would rise.  We saw a subtle 
increase in NALCN levels, but this increase was not significant (Fig. 4.5.C and D).  
Interestingly, while overall NALCN levels were still lower in the control P15.5 samples 
compared to the P19.5 samples (Fig 4.5.E), when films were exposed longer to better visualize 
the NALCN bands at P15.5, we again saw an increased prevalence of the higher molecular 
weight band in the vehicle treated P15.5 (high progesterone) uterine tissue compared to the tissue 
from RU486 treated mice.  These data reiterate the upregulation of the ~180 kDa band in the 
presence of both exogenous and endogenous progesterone. The induction of the ~180 kDa band 
during periods of higher progesterone levels suggests that progesterone may also be behind the 
N-linked glycosylation observed in the mesometrial border of P14, P18, and P19 mice.  To 
confirm, we also analyzed the effects of PNGase F and endo H on the progesterone treated 
tissue.  Again, we observed that the ~160 kDa band was insensitive to treatment by PNGase F 
and endo H, but that the ~180 kDa band was dramatically shifted by PNGase F to a core 





Figure 4.5 Progesterone-mediated regulation of NALCN.   
A) Representative western blot of uterine membrane preparations from mice at pregnancy day 19.5 
(P19.5) after treatment with vehicle or progesterone (P4) on P17.5 and P18.5.  TR is the loading control.  
B) Quantification of NALCN levels from vehicle and progesterone treated mice.  n’s are 8 and 10, 
respectively.  Mann-Whitney t-test, ** P < 0.01.  C) Representative western blot of uterine membrane 
preparations from mice at P15.5 after treatment with RU486 or vehicle on P14.5.  TR is the loading 
control.  D) Quantification of NALCN levels from vehicle and RU486 treated mice. n’s are 12 and 10, 
respectively.  E) Western blot of NALCN levels in mouse uterine membrane preparations from the P19.5 
and P15.5 vehicle treated mice at the same exposure.  F) Western blot of endo H and PNGase F treated 
uterine membrane preps from a P19.5 vehicle treated mouse and a P19.5 progesterone treated mouse.  TR 
is the positive control.
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progesterone states and the mesometrial border that induces the expression of a glycosylated 
form of NALCN. 
 4.4 Discussion 
 In an organ that undergoes extreme change, like the uterus, the specific genes that are 
important for its function undergo dynamic regulation to facilitate these changes.  We found that 
NALCN is dynamically regulated in the uterus on multiple levels.  First, we demonstrated by 
western blot the differential expression of two NALCN isoforms (~160 kDa and ~180 kDa) in 
the mesometrial border and anti-mesometrial section, and that the larger isoform undergoes N-
linked glycosylation.  We also showed that NALCN levels change over the estrus cycle, and in 
response to progesterone and RU486 treatment.  Increases in progesterone, and stages of the 
estrus cycle when the estrogen to progesterone ratio is decreased, downregulates NALCN protein 
levels.  During periods with higher levels of progesterone, we also saw an increased incidence of 
the ~180 kDa, PNGase F-sensitive protein.  Our discovery that NALCN undergoes dynamic 
regulation in the uterus, takes our findings beyond the modest concept that NALCN is expressed 
and active in the uterus, to supporting the notion that NALCN is an important contributor to 
uterine function and therefore needs to be modulated in order to drive changes in uterine activity. 
 Our results reinforce the findings of others who have shown the regulation of a number of 
ion channels in the uterus throughout pregnancy.  L-type calcium channels are the main ion 
channel responsible for the influx of calcium that initiate signaling processes and induce 
contraction.  These channels have been shown to gradually increase throughout pregnancy (38, 
39). Potassium channels are also regulated throughout pregnancy.  Many potassium channels, 
including SK3, BKCa, ROMK, and KATP, are down regulated in the uterus near term to facilitate 
membrane depolarization for the contractions of parturition (40-44).  However, some potassium 
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channels, primarily KCNQ, have been shown to be upregulated towards term as potassium 
currents are still essential in the contracting uterus to repolarize the membrane potential and 
avoid tonic contractions (45).  Additionally, the gap junction protein connexin-43, known for its 
role in increasing electrical connectivity in the uterus for parturition, is highly upregulated during 
labor and this process has also been shown to be dependent on the estrogen to progesterone ratio 
(46, 47).  Thus, changes in NALCN expression do not occur in isolation, but rather in 
coordination with the overall changing electrical dynamics of MSMCs. 
  Differential expression of NALCN between the mesometrial border and the anti-
mesometrial section supports literature demonstrating differing electrical properties between 
these two sections.  Kanda and Kuriyama demonstrated that myometrium from the mesometrial 
border was more hyperpolarized, showed a slower conduction velocity, and reduced oxytocin-
responsiveness (17).  Reduced excitability of this region has been corroborated by others (16, 
18).  Increased expression of the ~180 kDa NALCN band in the mesometrial border, and in 
progesterone treated uteri, suggests that this form of the channel may be inhibitory.  It is possible 
that this form of the channel is alternatively spliced, as the de-glycosylated core protein is 
smaller than the ~160 kDa non-glycosylated form.  Progesterone and estrogen have been shown 
to regulate alternative splicing of their target genes (48, 49) including ion channels (50, 51).  In 
the myometrium, estrogen downregulates an alternatively spliced isoform of the BKCa channel 
which is uniquely inhibited by protein kinase A (50).  Thus, although glycosylation of ion 
channels has been overwhelmingly associated with increased trafficking and activity of those 
channels (22), because this form of NALCN also may be alternatively spliced, glycosylation in 
this case may be stabilizing an inhibitory form of the channel.  If this isoform of NALCN is 
alternatively spliced, it is likely a novel isoform.  Alternatively spliced isoforms of NALCN have 
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been reported (52), but not extensively studied, and none of them closely match the isoform 
described here.  Finally, outside of alternative splicing, in the mesometrial border NALCN may 
differentially associate with accessory proteins like the calcium sensing receptor (CaSR) which 
negatively regulates NALCN, or with Na+-activated potassium channels which in the presence of 
the Na+-leak current, would actually cause membrane polarization. 
A limitation to these studies was that we did our analyses in whole uterine sections, 
meaning that our membrane preparations included myometrial and decidual tissue.  We expected 
that NALCN expression would be concentrated in the myometrium as ion channels are thought 
to play a greater role there, since the endometrium and decidua are thought to be less excitable 
tissues.  Furthermore, knocking out NALCN in the smooth muscle alone of mice resulted in a 
parturition phenotype indicating its specific importance in the myometrium.  However, ion 
channels including ENaC and CFTR are expressed in the endometrial epithelium and suggested 
to contribute to embryo implantation by controlling luminal fluid volume (reviewed in (53).  It is 
feasible that NALCN could also play a role in this process, as it has been linked to 
osmoregulation and hypernatremia (54).  Additionally, the progesterone receptor has been shown 
to be upregulated in the decidua of the mesometrial border compared to the anti-mesometrial 
section (55).  The co-occurrence of the ~180 kDa band in both the mesometrial border samples 
and the high progesterone samples, suggests that this mode of regulation of NALCN may be 
mediated by the progesterone receptor localized in the decidua of the mesometrial border.  
Therefore, future studies will determine whether NALCN levels differ between the endometrium 
or decidua, and the myometrium, and whether post-translational modifications of NALCN differ 
in these regions or even in individual cell types. 
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 Our findings have important implications in myometrium research as well as beyond.  
NALCN is expressed in a variety of tissues, including the pancreas, GI tract, and nervous 
system.  Hormonal control of this channel, if it occurs in these tissues, could have implications in 
sexually dimorphic diseases related to these systems.  Additionally, the discovery of a potentially 
novel isoform of the channel would have implications in the regulation of NALCN regardless of 
tissue.  
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Chapter 5: Discussion and Proposed Future 
Directions 
 
5.1 The Field of Myometrial Physiology 
Of all the unresolved questions in human and animal physiology, the question of what 
initiates labor and specifically how the uterus is able to remain quiescent for 40 weeks and then 
transition to a fully contractile state to deliver a baby, at first seems like a simple one.  However, 
after decades of both descriptive and mechanistic research, we still lack knowledge in some of 
the key aspects of normal labor physiology that would allow us to fully prevent and treat 
obstetric pathologies like preterm labor and dysfunctional labor.  Attempts to model the uterus 
after other well-studied contractile organs such as the heart or gastro-intestinal tract have only 
demonstrated that the uterus is fundamentally different, and therefore presents novel challenges.  
At present, researchers in the field of myometrial biology focus their efforts into three major 
areas that when taken as a whole, provide a clear picture of the regulation of uterine contractions 
across pregnancy and during labor.  These areas include 1) understanding the individual building 
blocks of the myometrium, the MSMCs, 2) understanding the changing local environment and 
tissue level signaling which alter the activity of MSMCs, and 3) understanding the regulation of 
uterine contractions at the whole organ level.  In my thesis work I attempted to study the role of 
the Na+ leak channel, NALCN, at all three levels of myometrial physiology.  Like the work of 
those before me, my research has answered some important questions and has also provided the 




5.2 NALCN as a Contributor of Na+ Current in MSMCs 
 As discussed extensively in the previous chapters, the electrical and contractile coupling 
of MSMCs is the driving mechanism behind uterine contractions.  Thus, the changes in uterine 
contractility necessary for labor to ensue are mediated by changes in the excitability of individual 
MSMCs.  It has long been understood that the duration, amplitude, and frequency of Ca2+ spikes 
in myometrial tissue are associated with the duration, force, and frequency of contractions (1).  It 
has also been demonstrated that the resting membrane potential in human and rodent 
myometrium becomes more depolarized over the course of pregnancy and at labor, contributing 
to increased uterine excitability needed for effective uterine contractions (2, 3).  Both RMP and 
the bursting pattern of the myometrium can be modified by changing the expression of the array 
of ion channels expressed in the myometrium (4, 5).  Most studies have focused solely on the 
regulation and activity of K+ and Ca2+ channels in the myometrium despite the known, but 
unclear role for Na+ currents.  In my thesis work, I discovered a novel Na+ leak current in human 
MSMCs, and determined that the recently identified Na+-leak channel, NALCN, contributes to 
this current (chapter 2).  This channel has been shown to increase spontaneous firing and burst 
activity in the tissues in which it is expressed (6-10).  In our genetic mouse model where 
NALCN is deleted in the myometrium, we determined that at term pregnancy, NALCN is 
necessary to sustain burst duration and the number of spikes per burst (chapter 3).  These data 
support the hypothesis that NALCN is an important modulator of uterine excitability in MSMCs.  
 Our finding that NALCN regulates burst duration in P19 myometrium corroborates the 
findings of others studying NCA (C. elegans NALCN equivalent) in C. elegans pre-motor 
interneurons, NALCN in the murine brain stem and pars reticulata neurons of the substantia 
nigra (8), and NALCN in murine interstitial cells of Cajal (ICCs) (11).  In C. elegans, a 
 120 
 
depolarizing pulse to pre-motor interneurons initiates a train of rhythmic post-synaptic current 
bursts (rPSCs) that corresponded with bursting action potentials (9).  In NCA loss of function 
mutants, the initial action potential in response to the depolarizing pulse remained, but the 
rhythmic post-stimulation bursts were lost.  In this model, NCA seems to have no role in 
initiating the primary burst, but plays an integral role in sustaining persistent bursting activity 
required for sustained locomotion in these worms.  In studies examining spontaneous firing in 
the murine nervous system, NALCN knockouts exhibited hyperpolarized resting membrane 
potential and a decreased spontaneous firing rate (6, 8).  In murine ICCs, substance P (SP) 
induces temporary prolonged depolarization of the membrane potential through a tachykinin 
receptor, and SFK dependent mechanism (11).  In NALCN-/- ICCs, SP-induced depolarization is 
significantly reduced. This agrees with our finding that NALCN contributes to mechanisms of 
sustained depolarization required for rhythmic activity.  The study of NALCN in ICCs also 
demonstrated that NALCN activity can be modulated by agonists including SP and 
acetylcholine, the mechanism for which requires the interaction of other members of what is now 
known as the NALCN complex. 
 Members of the NALCN complex, UNC79 and NLF-1 were expressed at the mRNA 
level in all human myometrium and mouse uterus samples analyzed (chapters 2 and 3).  Another 
member of the complex, UNC80 was expressed only in some laboring human samples, and some 
term non-laboring mouse uterus samples.  UNC80 has been found to be essential for NALCN 
activation by SP (TACR1) and low extracellular Ca2+ (removal of inhibition by CaSR), and may 
also be required for activation by acetylcholine (M3R) (12-14).  Future experiments parsing out 
the spatial and temporal regulation of UNC80 in human and mouse uterus will shed light on an 
important mode of NALCN regulation, and whether this channel may be modulated by agonists 
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in the myometrium.  Furthermore, because NLF-1 has been associated with coordinating the 
temporal regulation of NALCN in the circadian rhythm neurons of fruit flies, it will be important 
to assess NLF-1 and the entire NALCN complex levels in the myometrium across a 24-hour 
period (7).  This has additional implications in that spontaneous labor demonstrates a circadian 
dependence, with more labor initiating at night (15, 16).  Related to this, a pilot experiment 
assessing bursting activity in the mouse uterus during the night just before labor (performing the 
experiment 12 hours later than normal), showed myometrium had a longer burst duration and 
shorter burst interval than most P19 samples (Fig 5.1).  This agrees with findings of circadian 
regulation of NALCN, and increased expression of NALCN in the uterus in preparation for the 
onset of labor.  Future experiments may include assessment of myometrial bursting activity in 
smNALCN-/- during different light cycles to determine whether NALCN facilitates the prolonged 
bursts seen in the pilot experiment. 
5.3 Uterine NALCN in the Context of Pregnancy and Labor 
 Myometrial excitability changes across pregnancy in response to the changing hormonal 
milieu.  We found that burst duration, interval, and spike density of mouse myometrium changed 
throughout pregnancy.  However, many other ion channels are regulated throughout pregnancy 
that could be playing a role in these changes.  Furthermore, there are no specific blockers of 
NALCN to test the specific role of NALCN in myometrial excitability.  Thus, in order to 
determine whether NALCN regulates burst activity, we created the smNALCN-/- mouse and 
performed sharp electrode current clamp from P19 myometrium.  To address the role of NALCN 
in myometrial excitability throughout pregnancy, these experiments will need to be continued in 
myometrium samples from earlier stages of pregnancy.  It would be especially interesting to 





Figure 5.1 Effect of time of day and proximity to labor on uterine excitability.   
A) Representative membrane potential trace from a pregnancy day 19 (P19) recorded during the day.  
This mouse was sacrificed about 18 hours before normal delivery time.  B)  Membrane potential trace 




myometrium, when NALCN levels are at high and low levels, respectively.  We originally 
hypothesized that NALCN would play a greater role in regulating the burst interval, and not the 
burst duration.  This hypothesis was not correct in P19 myometrium, but it may be true of other 
stages of pregnancy when the levels of NALCN are higher. 
In addition to finding NALCN-dependent regulation of uterine excitability, we found that 
NALCN levels and putative NALCN isoforms were differentially regulated throughout 
pregnancy and the estrus cycle (chapter 3 and 4).  NALCN expression was inversely correlated 
with progesterone levels, and in fact, treating mice with progesterone reduced NALCN 
expression at P19.5.  These data suggest that NALCN is downregulated by progesterone in the 
mouse uterus, though the mechanism behind this downregulation is unknown.   
Progesterone signaling is classically thought to alter expression of target genes at the 
transcriptional level.  We saw a subtle reduction in NALCN mRNA later in pregnancy, but this 
change was not statistically significant.  It may be that NALCN transcription is subtly inhibited 
by progesterone through progesterone receptor-mediated transcriptional repression.  The 
NALCN promoter region contains a number of putative hormone receptor binding sites (Fig 5.2).  
Regulation of NALCN at the transcriptional level could be determined by further qRT-PCR 
analysis of NALCN mRNA levels in control P19.5 uterine tissue compared to tissue from a 
P19.5 mouse treated with progesterone.  Alternatively, progesterone may indirectly reduce 
NALCN stability.  It may do so by regulating the expression of NALCN complex proteins, NLF-
1, UNC79, or UNC80, which can aid in its localization to the plasma membrane.  Additionally, 
other progesterone targets may contribute to NALCN stability.  For example, progesterone was 





Figure 5.2 Transcription factor consensus sites in the NALCN promoter. 
NALCN promoter regions in the human and mouse with highlighted transcription factor consensus 
sequence sites.  Transcription start site (TSS), estrogen response element (ERE), glucocorticoid response 




in the proteasome (17).  Future studies could include time course experiments to determine 
whether progesterone affects the stability of NALCN protein. 
 Progesterone withdrawal, an initiator of labor, occurs by a different mechanism in human 
myometrium compared to the rodent.  In humans, circulating progesterone levels remain high, 
and the human myometrium undergoes a functional withdrawal of progesterone (discussed in 
chapter 1).  This functional withdrawal is in part mediated by the differential expression and 
functionality of progesterone receptors A and B.  PR-B is associated with the conventional 
function of progesterone in maintaining quiescence, whereas PR-A is associated with the term 
related increase in uterine excitability.  Although we did not see a significant change in NALCN 
mRNA levels from the myometrium of women in PTNL, TNL, PTL, or TL (chapter 2), this is 
likely due to the variability in the timing (both time of day and gestational length) of sample 
acquisition, the variability across a human population, and the fact that the samples were taken 
from the less contractile lower uterine segment.  Thus, to determine whether NALCN is 
regulated by progesterone in human MSMCs, cell lines may present a more consistent model.  I 
performed studies in a human myometrial cell line that had been engineered to express PRA and 
PRB under the control of the Tet-ON and RheoSwitch promoters (18).  In these cells the 
PRA:PRB ratio can be controlled by the dose of doxycycline or rheostat ligand.  I observed no 
clear pattern of NALCN regulation by progesterone, regardless of the PRA:PRB ratio in these 
cells.  This was possibly due to the fundamental changes that can occur in cell lines when they 
are immortalized.  Additionally, there were many NALCN antibody-reactive bands that made it 
difficult to parse out true changes in NALCN levels.  Preliminary experiments in cultured 
primary human MSMCs have shown that NALCN is upregulated by progesterone when the 




Figure 5.3 Progesterone-mediated regulation of NALCN in primary human MSMCs.   
A) MSMCs from a term, non-laboring woman, treated with 100 nM progesterone (P4) for 48 and 72 
hours.  PR-A and PR-B levels are near equal.  B) MSMCs from a term, non-laboring woman, treated with 
100 nM P4 for 48 and 72 hours.  PR-A is dominant.  A and B) GAPDH is used as a loading control.
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However, more experiments will need to be performed to determine if this is a mechanism for 
NALCN regulation, and they may need to be performed in large number to increase the number 
of samples with a high PRA:PRB ratio. 
We also found that progesterone has an effect on NALCN post-transcriptional regulation. 
In the whole uterus under high progesterone states, and specifically in the mesometrial border, 
we saw increased expression of a PNGase F-sensitive ~180 kDa isoform of NALCN.  
Interestingly, when deglycosylated, this isoform ends up being smaller than the original, at only 
~140 kDa.  This indicates that the ~160 kDa band is either resistant to deglycoslation by PNGase 
F, perhaps because it is O-glycosylated instead of N-glycosylated, or that the two isoforms have 
a different core structure.  Future studies using immunoblot analysis of the mesometrial border 
from P14 and P18 smNALCN-/- mice will confirm the identity of the ~180 kDa band as NALCN.  
Additionally, RT-PCR analysis of NALCN from the mesometrial border would enable 
identification of alternative splicing isoforms.  Currently, there are no reports of glycosylation of 
NALCN and thus we do not know if this would alter channel function.  Further investigation 
using western blot analysis and patch clamp recordings of NALCN mutants lacking 
glycosylation sites, would enable us to define the role of glycosylation on NALCN function. 
Progesterone is thought to serve its ‘anti-labor’ function, by downregulating 
inflammatory genes (18), known risk factors in initiating labor.  Intrauterine infection is a 
leading cause of preterm birth.  In mice, intrauterine injection of lipopolysaccharide (LPS) 
induces preterm labor.  Many of the mechanisms associated with infection associated preterm 
birth are similar to those found in term, spontaneous labor.  For example, myometrial samples 
from term laboring women show a large increase in the presence of leukocytes including 
macrophages and neutrophils (19, 20), and increased expression of cytokines and chemokines 
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including IL-6, IL-1β, TNF-α, and IL-8 (20).  These induce labor by stimulating the production 
of the uterotonin, prostaglandin F2α. Thus, future experiments should determine if NALCN levels 
in the myometrium are regulated by pro-inflammatory genes and whether progesterone inhibition 
of NALCN is actually an indirect effect of progesterone’s anti-inflammatory actions.  
Additionally, future experiments could address whether NALCN is an important mediator of 
infection-induced preterm birth by performing intrauterine injections of LPS in smNALCN-/- and 
comparing outcomes to flox control mice. 
5.4 NALCN in Achieving Organ-level Uterine Contractions 
Beyond understanding the role of a particular target gene in myometrial cell and tissue-
level excitability, and knowing its regulation in the context of pregnancy, it is essential to 
determine whether this function is substantial enough to translate into a change at the whole 
organ level.  For labor to be successful, uterine contractions must not only be forceful and 
rhythmic, but must also be coordinated throughout the entire uterus.  In women, physicians 
monitor labor progress by measuring cervical dilation, as well as contraction frequency and 
amplitude via a tocodynamometer (at the abdominal surface), or by an inserted intrauterine 
pressure catheter.  Although these are still the main methods of assessing labor progress, they are 
imprecise in their measurement.  These measurements also cannot address key questions about 
uterine contractility such as how contractions propagate throughout the organ, where the 
contractions originate, whether there is a pacemaker region, and whether the contractions will be 
effective and represent true labor. Whole organ measurements of electrical activity, such as those 




 One device that was developed to study organ level electrical activity of the uterus in 
women is the SQUID array, which is a non-invasive magnetomyography device.  It measures 
electrical activity across the front surface of the human uterus, and it is being used to understand 
patterns of uterine contractility so that physicians may be able to better predict preterm labor 
and/or false labor.  Data from the SQUID array, as well as some electromyographical studies (21, 
22) and an in vitro electrode array study of the guinea pig uterus (23), have been unable to 
identify a specific region of the uterus with pacemaking activity.  Although the spontaneous and 
reliable nature of uterine contractions suggests that uterine activity is driven by a biological 
pacemaker, studies indicate that electrical activity could initiate anywhere (23).  Additionally, 
the theory that the electrical signal could begin in one part of the uterus and then spread evenly 
throughout the entire organ has been discounted by many investigators, in which they found 
propagation distances were shorter than that required to cover the whole organ, and did not 
follow any distinct path (23-25).  This has left many wondering how synchronous contractions 
could occur at the whole organ level.   
With no strong evidence for a distinct pacemaking node or path of propagation, 
accumulating experimental evidence and mathematical models suggest that the rhythmicity of 
uterine contractions during labor are driven by the increased connectivity of MSMCs and 
mechanical stimulation (24, 26).  Smith et al. suggest that depolarizations of MSMCs during 
mid-pregnancy remain locally isolated, while at term because of increased cell-to-cell 
connectivity driven by the upregulation of gap junctions, local depolarization can spread to 
surrounding tissue (26).  This creates depolarized areas large enough to produce regional 
contractions, which induce mechanically-stimulated contraction of the neighboring tissue.  This 
drives a chain reaction resulting in organ level contractions.  Smith et al. relate this to the activity 
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of a soccer stadium crowd, wherein spontaneous local activity of individual members (MSMCs), 
spreads through increased connectivity to form coordinated chants and waves (electrical bursts).  
This model wonderfully conceptualizes the intricate coordination of MSMC activity that occurs 
during parturition.  Although it mainly focuses on the activity of MSMCs as a group, it also 
implies that the individual MSMCs must be able to initiate and propagate spontaneous bursting 
activity.  In studying NALCN, we sought to address the physiological mechanisms which make 
the individual members prone to initiate and sustain excitable activity. 
We addressed the role of NALCN in organ level activity by creating a smooth muscle 
specific NALCN knockout mouse and assessing its labor outcomes.  We found that smNALCN-/- 
mice had a higher rate of either prolonged or dysfunctional labor.  Because our data showed 
reduced burst duration in smNALCN-/-  myometrium, and because it is well known that NALCN 
regulates tissue excitability, we associated the labor problems in the smNALCN-/- mice with 
inefficient uterine contractility.  Although the current evidence supports our assumption, future 
studies measuring uterine contractions in smNALCN-/- mice need to be performed.  Contractions 
can be studied in an in vitro setting by isometric tension recording of myometrial strips and these 
provide baseline information about the contractility pattern of a piece of uterine tissue.  Mouse 
uterine activity can also be measured in vivo with the use of intrauterine pressure catheters, the 
method for which our lab was first to establish (27, 28).  These experiments would provide an 
important validation of our hypothesized mechanism of smNALCN-/- labor dysfunction. 
5.5 Concluding Remarks 
 Labor contractions are an essential component to the evolutionary success of placental 
viviparous species, and yet they are often taken for granted.  In humans especially, labor 
contractions must be well-coordinated to deliver a live offspring and maintain maternal health.  
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Evolutionary selection in humans for both bipedalism and an enlarged brain has made the infant 
head to maternal pelvis a tighter fit and more tortuous passage, and also unique to humans, it 
forces the need for assisted birth (29, 30).  Although many births carried out in the home or the 
hospital proceed without complication, still many women will require medical intervention (31).  
Physicians rely heavily on methods including labor induction and augmentation by oxytocin, or 
surgical delivery by caesarean section, which still sustain a substantial risk of morbidity and 
mortality for mother and baby (32-35).  Thus, endeavors to increase our understanding of the 
mechanisms behind uterine contractions are crucial in the efforts to improve medical assistance 
to women undergoing dysfunctional labor.   
 In our studies, we identified the novel expression of the Na+-leak channel in human 
MSMCs.  Through the use of a smooth muscle NALCN knockout mouse model, we established 
the role for this channel in modulating uterine excitability and in facilitating successful and 
efficient parturition.  In the future, it will be important to establish the role and regulation of this 
channel in coordinating human uterine contractility.  Additionally, high-throughput small 
molecule screening methods to identify NALCN-specific agonists and antagonists will be 
essential in the application of this knowledge to the treatment of women, as well as to those 
suffering from diseases associated with NALCN mutations.  As is often the case in medical 
research, our findings of a novel mediator of uterine contractions creates optimism for the 
implications of its future applications, but also generates many new questions to be addressed. 
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